Updated on 2025/12/31

写真a

 
FUKUSHIMA TOSHIAKI
 
Organization
Institute of Integrated Research Cell Biology Center Associate Professor
Title
Associate Professor
Profile

東京大学大学院 農学生命科学研究科 応用動物科学専攻 動物細胞制御学研究室、および広島大学 医歯薬保健学研究院 医化学研究室にて、動物細胞におけるインスリンや増殖因子のシグナル伝達を研究した。その後、東京工業大学 科学技術創成研究院 駒田研究室にて、タンパク質ユビキチン化を介した増殖因子シグナルの制御とその異常による疾患発症の分子機構の研究を行った。現在は、東京科学大学 総合研究院 細胞制御工学研究センターにて研究室を主催し、「ユビキチンシステムによる細胞機能の新しい制御機構と、疾患や老化におけるその変容の解明」に取り組んでいる。

External link

News & Topics

▼display all

Degree

  • 博士(農学) ( 2005.3   東京大学大学院 )

Research Interests

  • がん

  • ユビキチン

  • シグナル伝達

  • インスリン

  • 増殖因子

  • 糖尿病

  • 腫瘍

  • 細胞老化

Research Areas

  • Life Science / Animal life science

  • Life Science / Medical biochemistry

  • Life Science / Cell biology

Education

  • The University of Tokyo   Graduate School of Agricultural and Life Sciences   Animal Resource Sciences

    2000.4 - 2005.3

      More details

  • The University of Tokyo

    1998.4 - 2000.3

      More details

Research History

  • Institute of Science Tokyo   Institute of Integrated Research   Associate Professor

    2024.11

      More details

  • Tokyo Institute of Technology

    2015.4 - 2024.10

      More details

  • Hiroshima University   Assistant Professor

    2010.4 - 2015.3

      More details

  • The University of Tokyo   Graduate School of Agricultural and Life Sciences   Researcher

    2005.4 - 2010.3

      More details

Professional Memberships

Papers

  • Molecular bases for USP48 cis-activity regulation and hyperactivation by Cushing's disease-associated mutations

    Gai Ando, Yasutaka Tsujimoto, Kei Moritsugu, Keijun Kakihara, Akinori Kidera, Shozo Yamada, Masayuki Komada, Hidenori Fukuoka, Toshiaki Fukushima

    2025.12

  • A possible function of Nik-related kinase in the labyrinth layer of delayed delivery mouse placentas Reviewed International journal

    Yomogita H, Ito H, Hashimoto K, Kudo A, Fukushima T, Endo T, Hirate Y, Akimoto Y, Komada M, Kanai Y, Miyasaka N, Kanai-Azuma M

    J Reprod Dev Mol   Vol. 69 ( No. 1 )   32 - 40   2025.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In mice and humans, Nik-related protein kinase (Nrk) is an X-linked gene that encodes a serine/threonine kinase belonging to GCK group 4. Nrk knockout (Nrk KO) mice exhibit delayed delivery, possibly due to defective communication between the Nrk KO conceptus and its mother. However, the mechanism of delayed labor remains largely unknown. Here, we found that in pregnant mothers with the Nrk KO conceptus, the serum progesterone (P4) and placental lactogen (PL-2) concentrations in late pregnancy were higher than those in the wild type. Moreover, we demonstrated that Nrk is expressed in trophoblast giant cells (TGCs) and syncytiotrophoblast-2 (SynT-2) in the labyrinth layer of the mouse placenta. In the human placenta, NRK is also expressed in Syn-T of villi. Both human Syn-T and mouse TGCs of the labyrinth layer are present within fetal tissues that are in direct contact with the maternal blood. The labyrinth layer of the Nrk KO conceptus was gigantic, with enlarged cytoplasm and Golgi bodies in the TGCs. To investigate the function of Nrk in the labyrinth layer, a differentially expressed gene (DEG) analysis was performed. The DEG analysis revealed that labor-promoting factors, such as prostaglandins, were decreased, and pregnancy-maintaining factors, such as the prolactin family and P4 receptor, were increased. These findings suggest that the Nrk KO mice exhibit delayed delivery owing to high P4 concentrations caused by the hypersecretion of pregnancy-maintaining factors, such as PL-2, from the placenta.

    DOI: 10.1262/jrd.2022-120

    PubMed

    researchmap

  • マウス、ヒト胎盤におけるNrk下流遺伝子群と分娩遅延の関連について Reviewed

    蓬田裕, 高峰愛幸, 伊藤日加瑠, 平手良和, 福嶋俊明, 駒田雅之, 金井克晃, 宮坂尚幸, 金井正美

    2025.12

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • The enzyme activity of USP8 is regulated by the intramolecular interaction of the USP domain and the WW domain

    Keijun Kakihara, Kengo Asamizu, Akinori Endo, Kei Moritsugu, Akira Kato, Masayuki Komada, Toshiaki Fukushima

    2025.12

     More details

    Language:English   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model Reviewed International coauthorship International journal

    H. Okubo, H. Sakoda, A. Kushiyama, M. Fujishiro, Y. Nakatsu, T. Fukushima, Y. Matsunaga, H. Kamata, T. Asahara, Y. Yoshida, O. Chonan, M. Iwashita, F. Nishimura, T. Asano

    Am J Physiol Gastrointest Liver Physiol   Vol. 305 ( No. 12 )   G911 - 8   2025.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Gut microbiota alterations are associated with various disorders. In this study, gut microbiota changes were investigated in a methionine-choline-deficient (MCD) diet-induced nonalcoholic steatohepatitis (NASH) rodent model, and the effects of administering Lactobacillus casei strain Shirota (LcS) on the development of NASH were also investigated. Mice were divided into three groups, given the normal chow diet (NCD), MCD diet, or the MCD diet plus daily oral administration of LcS for 6 wk. Gut microbiota analyses for the three groups revealed that lactic acid bacteria such as Bifidobacterium and Lactobacillus in feces were markedly reduced by the MCD diet. Interestingly, oral administration of LcS to MCD diet-fed mice increased not only the L. casei subgroup but also other lactic acid bacteria. Subsequently, NASH development was evaluated based on hepatic histochemical findings, serum parameters, and various mRNA and/or protein expression levels. LcS intervention markedly suppressed MCD-diet-induced NASH development, with reduced serum lipopolysaccharide concentrations, suppression of inflammation and fibrosis in the liver, and reduced colon inflammation. Therefore, reduced populations of lactic acid bacteria in the colon may be involved in the pathogenesis of MCD diet-induced NASH, suggesting normalization of gut microbiota to be effective for treating NASH.

    DOI: 10.1152/ajpgi.00225.2013

    PubMed

    researchmap

  • Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model Reviewed International journal

    Y. Nakatsu, Y. Otani, H. Sakoda, J. Zhang, Y. Guo, H. Okubo, A. Kushiyama, M. Fujishiro, T. Kikuch, T. Fukushima, H. Ohno, Y. Tsuchiya, H. Kamata, A. Nagamachi, T. Inaba, F. Nishimura, H. Katagiri, S. Takahashi, H. Kurihara, T. Uchida, T. Asano

    J Biol Chem   Vol. 287 ( No. 53 )   44526 - 35   2025.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nonalcoholic steatohepatitis (NASH) is a disorder characterized by simultaneous fat accumulation and chronic inflammation in the liver. In this study, Pin1 expression was revealed to be markedly increased in the livers of mice with methionine choline-deficient (MCD) diet-induced NASH, a rodent model of NASH. In addition, Pin1 KO mice were highly resistant to MCD-induced NASH, based on a series of data showing simultaneous fat accumulation, chronic inflammation, and fibrosis in the liver. In terms of Pin1-induced fat accumulation, it was revealed that the expression levels of peroxisome proliferator-activated receptor α and its target genes were higher in the livers of Pin1 KO mice than in controls. Thus, resistance of Pin1 KO mice to hepatic steatosis is partially attributable to the lack of Pin1-induced down-regulation of peroxisome proliferator-activated receptor α, although multiple other mechanisms are apparently involved. Another mechanism involves the enhancing effect of hematopoietic Pin1 on the expressions of inflammatory cytokines such as tumor necrosis factor and monocyte chemoattractant protein 1 through NF-κB activation, eventually leading to hepatic fibrosis. Finally, to distinguish the roles of hematopoietic or nonhematopoietic Pin1 in NASH development, mice lacking Pin1 in either nonhematopoietic or hematopoietic cells were produced by bone marrow transplantation between wild-type and Pin1 KO mice. The mice having nonhematopoietic Pin1 exhibited fat accumulation without liver fibrosis on the MCD diet. Thus, hepatic Pin1 appears to be directly involved in the fat accumulation in hepatocytes, whereas Pin1 in hematopoietic cells contributes to inflammation and fibrosis. In summary, this is the first study to demonstrate that Pin1 plays critical roles in NASH development. This report also raises the possibility that hepatic Pin1 inhibition to the appropriate level might provide a novel therapeutic strategy for NASH.

    DOI: 10.1074/jbc.M112.397133

    PubMed

    researchmap

  • Deficiency of X-Linked Protein Kinase Nrk during Pregnancy Triggers Breast Tumor in Mice Reviewed International journal

    T. Yanagawa, K. Denda, T. Inatani, T. Fukushima, T. Tanaka, N. Kumaki, Y. Inagaki, M. Komada

    Am J Pathol   Vol. 186 ( No. 10 )   2751 - 60   2025.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The onset and/or growth of breast tumor are controlled, at least in part, by estrogen. Therefore, to prevent the development of breast tumor, estrogen-dependent proliferation of mammary epithelial cells during pregnancy needs to be suppressed once the mammary gland is fully developed to enable lactation. However, the underlying molecular mechanisms remain unknown. Nrk is an X-linked protein serine/threonine kinase in the germinal center kinase family. Herein, we demonstrate a frequent occurrence of breast tumors in homozygous and heterozygous Nrk mutant mice that have experienced pregnancy/parturition. The tumors never developed in the mutant mice without a history of pregnancy/parturition. They exhibited histopathological features of noninvasive tubular adenocarcinoma, and expressed estrogen receptor α. At late gestation when estrogen receptor α expression was significantly reduced in the wild-type mammary gland, grossly normal mammary glands in the pregnant Nrk mutant mice occasionally contained hyperplastic foci continuously expressing the receptor. Consistently, Nrk expression was induced in the wild-type mammary gland at this period of pregnancy. On the other hand, the pregnant Nrk mutant mice also showed elevated blood estrogen levels at late gestation. We suggest that Nrk suppresses the excessive proliferation of mammary epithelial cells during pregnancy, and the impairment of this regulatory system leads to frequent occurrence of breast tumor in Nrk mutant mice.

    DOI: 10.1016/j.ajpath.2016.06.005

    PubMed

    researchmap

  • Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the gamma subunit Reviewed International journal

    Y. Nakatsu, M. Iwashita, H. Sakoda, H. Ono, K. Nagata, Y. Matsunaga, T. Fukushima, M. Fujishiro, A. Kushiyama, H. Kamata, S. Takahashi, H. Katagiri, H. Honda, H. Kiyonari, T. Uchida, T. Asano

    J Biol Chem   Vol. 290 ( No. 40 )   24255 - 66   2025.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AMP-activated protein kinase (AMPK) plays a critical role in metabolic regulation. In this study, first, it was revealed that Pin1 associates with any isoform of γ, but not with either the α or the β subunit, of AMPK. The association between Pin1 and the AMPK γ1 subunit is mediated by the WW domain of Pin1 and the Thr(211)-Pro-containing motif located in the CBS domain of the γ1 subunit. Importantly, overexpression of Pin1 suppressed AMPK phosphorylation in response to either 2-deoxyglucose or biguanide stimulation, whereas Pin1 knockdown by siRNAs or treatment with Pin1 inhibitors enhanced it. The experiments using recombinant Pin1, AMPK, LKB1, and PP2C proteins revealed that the protective effect of AMP against PP2C-induced AMPKα subunit dephosphorylation was markedly suppressed by the addition of Pin1. In good agreement with the in vitro data, the level of AMPK phosphorylation as well as the expressions of mitochondria-related genes, such as PGC-1α, which are known to be positively regulated by AMPK, were markedly higher with reduced triglyceride accumulation in the muscles of Pin1 KO mice as compared with controls. These findings suggest that Pin1 plays an important role in the pathogenic mechanisms underlying impaired glucose and lipid metabolism, functioning as a negative regulator of AMPK.

    DOI: 10.1074/jbc.M115.658559

    PubMed

    researchmap

  • Pin1 associates with and induces translocation of CRTC2 to the cytosol, thereby suppressing cAMP-responsive element transcriptional activity Reviewed International journal

    Y. Nakatsu, H. Sakoda, A. Kushiyama, H. Ono, M. Fujishiro, N. Horike, M. Yoneda, H. Ohno, Y. Tsuchiya, H. Kamata, H. Tahara, T. Isobe, F. Nishimura, H. Katagiri, Y. Oka, T. Fukushima, S. Takahashi, H. Kurihara, T. Uchida, T. Asano

    J Biol Chem   Vol. 285 ( No. 43 )   33018 - 27   2025.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pin1 is a unique regulator, which catalyzes the conversion of a specific phospho-Ser/Thr-Pro-containing motif in target proteins. Herein, we identified CRTC2 as a Pin1-binding protein by overexpressing Pin1 with Myc and FLAG tags in mouse livers and subsequent purification of the complex containing Pin1. The association between Pin1 and CRTC2 was observed not only in overexpression experiments but also endogenously in the mouse liver. Interestingly, Ser(136) in the nuclear localization signal of CRTC2 was shown to be involved in the association with Pin1. Pin1 overexpression in HepG2 cells attenuated forskolin-induced nuclear localization of CRTC2 and cAMP-responsive element (CRE) transcriptional activity, whereas gene knockdown of Pin1 by siRNA enhanced both. Pin1 also associated with CRTC1, leading to their cytosol localization, essentially similar to the action of CRTC2. Furthermore, it was shown that CRTC2 associated with Pin1 did not bind to CREB. Taken together, these observations indicate the association of Pin1 with CRTC2 to decrease the nuclear CBP·CRTC·CREB complex. Indeed, adenoviral gene transfer of Pin1 into diabetic mice improved hyperglycemia in conjunction with normalizing phosphoenolpyruvate carboxykinase mRNA expression levels, which is regulated by CRE transcriptional activity. In conclusion, Pin1 regulates CRE transcriptional activity, by associating with CRTC1 or CRTC2.

    DOI: 10.1074/jbc.M110.137836

    PubMed

    researchmap

  • HSP90 interacting with IRS-2 is involved in cAMP-dependent potentiation of IGF-I signals in FRTL-5 cells Reviewed International journal

    T. Fukushima, H. Okajima, D. Yamanaka, M. Ariga, S. Nagata, A. Ito, M. Yoshida, T. Asano, K. Chida, F. Hakuno, S. Takahashi

    Mol Cell Endocrinol   Vol. 344 ( No. 1-2 )   81 - 9   2025.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prolonged stimulation of FRTL-5 thyroid cells with cAMP-generating agents including thyroid-stimulating hormone (TSH) or cAMP analogues potentiates tyrosine phosphorylation of insulin receptor substrate (IRS)-2 triggered by insulin-like growth factor (IGF)-I, leading to enhancement of IGF-I-dependent proliferation. Because we identified HSP90 as an IRS-2-interacting protein, the roles of HSP90 in potentiation of IGF signals through IRS-2 were investigated. We found that prolonged dibutyryl cAMP treatment induced serine/threonine phosphorylation of IRS-2. Using a specific inhibitor of HSP90 chaperone activity, geldanamycin, or small interfering RNA against HSP90, we showed that HSP90 mediates cAMP-induced serine/threonine phosphorylation of IRS-2. Furthermore, inhibition of HSP90 by geldanamycin during dibutyryl cAMP pretreatment of cells for 24h suppressed cAMP-dependent potentiation of tyrosine phosphorylation of IRS-2 induced by IGF-I. Taking together, we conclude that HSP90 interacting with IRS-2 mediates cAMP-dependent serine/threonine phosphorylation of IRS-2 via its chaperone activity, leading to potentiation of tyrosine phosphorylation of IRS-2 induced by IGF-I.

    DOI: 10.1016/j.mce.2011.06.029

    PubMed

    researchmap

  • Familial short stature is associated with a novel dominant-negative heterozygous insulin-like growth factor 1 receptor (IGF1R) mutation Reviewed International journal

    Y. Kawashima, F. Hakuno, S. Okada, T. Hotsubo, T. Kinoshita, M. Fujimoto, R. Nishimura, T. Fukushima, K. Hanaki, S. Takahashi, S. Kanzaki

    Clin Endocrinol (Oxf)   Vol. 81 ( No. 2 )   312 - 4   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cen.12317

    PubMed

    researchmap

  • Insulin receptor substrate-1 (IRS-1) forms a ribonucleoprotein complex associated with polysomes Reviewed International journal

    A. Ozoe, M. Sone, T. Fukushima, N. Kataoka, T. Arai, K. Chida, T. Asano, F. Hakuno, S. Takahashi

    FEBS Lett   Vol. 587 ( No. 15 )   2319 - 24   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin receptor substrates (IRSs) are known to play important roles in mediating intracellular insulin-like growth factors (IGFs)/insulin signaling. In this study, we identified components of messenger ribonucleoprotein (mRNP) as IRS-1-associated proteins. IRS-1 complex formation analysis revealed that IRS-1 is incorporated into the complexes of molecular mass more than 1000 kDa, which were disrupted by treatment with RNase. Furthermore, oligo(dT) beads precipitated IRS-1 from cell lysates, showing that the IRS-1 complexes contained messenger RNA. Taken together with the data that IRS-1 was fractionated into the polysome-containing high-density fractions, we concluded that IRS-1 forms the novel complexes with mRNPs.

    DOI: 10.1016/j.febslet.2013.05.066

    PubMed

    researchmap

  • Resistin-like molecule beta is abundantly expressed in foam cells and is involved in atherosclerosis development Reviewed International coauthorship International journal

    A. Kushiyama, H. Sakoda, N. Oue, M. Okubo, Y. Nakatsu, H. Ono, T. Fukushima, H. Kamata, F. Nishimura, T. Kikuchi, M. Fujishiro, K. Nishiyama, H. Aburatani, S. Kushiyama, M. Iizuka, N. Taki, J. Encinas, K. Sentani, N. Ogonuki, A. Ogura, S. Kawazu, W. Yasui, Y. Higashi, H. Kurihara, H. Katagiri, T. Asano

    Arterioscler Thromb Vasc Biol   Vol. 33 ( No. 8 )   1986 - 93   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Resistin-like molecule (RELM) β is a secretory protein homologous to resistin and reportedly contributes to local immune response regulation in gut and bronchial epithelial cells. However, we found that activated macrophages also express RELMβ and thus investigated the role of RELMβ in the development of atherosclerosis. APPROACH AND RESULTS: It was demonstrated that foam cells in atherosclerotic lesions of the human coronary artery abundantly express RELMβ. RELMβ knockout ((-/-)) and wild-type mice were mated with apolipoprotein E-deficient background mice. RELMβ(-/-) apolipoprotein E-deficient mice exhibited less lipid accumulation in the aortic root and wall than RELMβ(+/+) apolipoprotein E-deficient mice, without significant changes in serum lipid parameters. In vitro, RELMβ(-/-) primary cultured peritoneal macrophages (PCPMs) exhibited weaker lipopolysaccharide-induced nuclear factor-κB classical pathway activation and inflammatory cytokine secretion than RELMβ(+/+), whereas stimulation with RELMβ upregulated inflammatory cytokine expressions and increased expressions of many lipid transporters and scavenger receptors in PCPMs. Flow cytometric analysis revealed inflammatory stimulation-induced RELMβ in F4/80(+) CD11c(+) PCPMs. In contrast, the expressions of CD11c and tumor necrosis factor were lower in RELMβ(-/-) PCPMs, but both were restored by stimulation with recombinant RELMβ. CONCLUSIONS: RELMβ is abundantly expressed in foam cells within plaques and contributes to atherosclerosis development via lipid accumulation and inflammatory facilitation.

    DOI: 10.1161/ATVBAHA.113.301546

    PubMed

    researchmap

  • Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation Reviewed International journal

    T. Fukushima, Y. Nakamura, D. Yamanaka, T. Shibano, K. Chida, S. Minami, T. Asano, F. Hakuno, S. Takahashi

    J Biol Chem   Vol. 287 ( No. 35 )   29713 - 21   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Continuous stimulation of cells with insulin-like growth factors (IGFs) in G(1) phase is a well established requirement for IGF-induced cell proliferation; however, the molecular components of this prolonged signaling pathway that is essential for cell cycle progression from G(1) to S phase are unclear. IGF-I activates IGF-I receptor (IGF-IR) tyrosine kinase, followed by phosphorylation of substrates such as insulin receptor substrates (IRS) leading to binding of signaling molecules containing SH2 domains, including phosphatidylinositol 3-kinase (PI3K) to IRS and activation of the downstream signaling pathways. In this study, we found prolonged (>9 h) association of PI3K with IGF-IR induced by IGF-I stimulation. PI3K activity was present in this complex in thyrocytes and fibroblasts, although tyrosine phosphorylation of IRS was not yet evident after 9 h of IGF-I stimulation. IGF-I withdrawal in mid-G(1) phase impaired the association of PI3K with IGF-IR and suppressed DNA synthesis the same as when PI3K inhibitor was added. Furthermore, we demonstrated that Tyr(1316)-X-X-Met of IGF-IR functioned as a PI3K binding sequence when this tyrosine is phosphorylated. We then analyzed IGF signaling and proliferation of IGF-IR(-/-) fibroblasts expressing exogenous mutant IGF-IR in which Tyr(1316) was substituted with Phe (Y1316F). In these cells, IGF-I stimulation induced tyrosine phosphorylation of IGF-IR and IRS-1/2, but mutated IGF-IR failed to bind PI3K and to induce maximal phosphorylation of GSK3β and cell proliferation in response to IGF-I. Based on these results, we concluded that PI3K activity bound to IGF-IR, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.

    DOI: 10.1074/jbc.M112.393074

    PubMed

    researchmap

  • Novel missense mutation in the IGF-I receptor L2 domain results in intrauterine and postnatal growth retardation Reviewed International journal

    Y. Kawashima, K. Higaki, T. Fukushima, F. Hakuno, J. Nagaishi, K. Hanaki, E. Nanba, S. Takahashi, S. Kanzaki

    Clin Endocrinol (Oxf)   Vol. 77 ( No. 2 )   246 - 54   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: IGFs play key roles in intrauterine and postnatal growth through the IGF-I receptor (IGF-IR). We identified a family bearing a new heterozygous missense mutation at the L2 domain of IGF-IR (R431L). METHOD: We analysed the nucleotide sequences of the IGF1R gene of the family. We prepared R(-) cells (fibroblasts with targeted disruption of the IGF-IR gene) expressing wild-type or R431L IGF-IR and performed functional analyses by evaluating IGF-I binding, IGF-I-stimulated DNA synthesis, tyrosine phosphorylation of IGF-IR and its substrates, and internalization by measuring [(125) I]IGF-I internalization. We also performed confocal microscopy analysis. RESULTS: We identified a family bearing a new heterozygous missense mutation at the L2 domain of IGF-IR (R431L) through an 8-year-old girl and her mother, both born with intrauterine growth retardation. In experiments conducted using cells homozygously transfected with the IGF-IR R431L mutation; (i) IGF-I binding was not affected; (ii) DNA synthesis induced by IGF-I was decreased; (iii) IGF-IR internalization stimulated by IGF-I was decreased and (iv) IGF-I-stimulated tyrosine phosphorylation was reduced IGF-IR by low concentrations of IGF-I and on insulin receptor substrate (IRS)-1 and IRS-2. CONCLUSION: A missense mutation (R431L) leads to the inhibition of cell proliferation, attenuation of IGF signalling and decrease in internalization of IGF-IR. The results of this study suggest a novel link between a mutation at the IGF-IR L2 domain and intrauterine and postnatal growth retardation.

    DOI: 10.1111/j.1365-2265.2012.04357.x

    PubMed

    researchmap

  • Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions Reviewed International journal

    J. Zhang, Y. Nakatsu, T. Shinjo, Y. Guo, H. Sakoda, T. Yamamotoya, Y. Otani, H. Okubo, A. Kushiyama, M. Fujishiro, T. Fukushima, Y. Tsuchiya, H. Kamata, M. Iwashita, F. Nishimura, H. Katagiri, S. Takahashi, H. Kurihara, T. Uchida, T. Asano

    J Biol Chem   Vol. 288 ( No. 28 )   20692 - 701   2025.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pin1 and Par14 are parvulin-type peptidyl-prolyl cis/trans isomerases. Although numerous proteins have been identified as Pin1 substrates, the target proteins of Par14 remain largely unknown. Par14 expression levels are increased in the livers and embryonic fibroblasts of Pin1 KO mice, suggesting a compensatory relationship between the functions of Pin1 and Par14. In this study, the association of Par14 with insulin receptor substrate 1 (IRS-1) was demonstrated in HepG2 cells overexpressing both as well as endogenously in the mouse liver. The analysis using deletion-mutated Par14 and IRS-1 constructs revealed the N-terminal portion containing the basic domain of Par14 and the two relatively C-terminal portions of IRS-1 to be involved in these associations, in contrast to the WW domain of Pin1 and the SAIN domain of IRS-1. Par14 overexpression in HepG2 markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events, PI3K binding with IRS-1 and Akt phosphorylation. In contrast, treating HepG2 cells with Par14 siRNA suppressed these events. In addition, overexpression of Par14 in the insulin-resistant ob/ob mouse liver by adenoviral transfer significantly improved hyperglycemia with normalization of hepatic PEPCK and G6Pase mRNA levels, and gene suppression of Par14 using shRNA adenovirus significantly exacerbated the glucose intolerance in Pin1 KO mice. Therefore, although Pin1 and Par14 associate with different portions of IRS-1, the prolyl cis/trans isomerization in multiple sites of IRS-1 by these isomerases appears to be critical for efficient insulin receptor-induced IRS-1 phosphorylation. This process is likely to be one of the major mechanisms regulating insulin sensitivity and also constitutes a potential therapeutic target for novel insulin-sensitizing agents.

    DOI: 10.1074/jbc.M113.485730

    PubMed

    researchmap

  • Paraquat-induced oxidative stress represses phosphatidylinositol 3-kinase activities leading to impaired glucose uptake in 3T3-L1 adipocytes Reviewed International journal

    M. Shibata, F. Hakuno, D. Yamanaka, H. Okajima, T. Fukushima, T. Hasegawa, T. Ogata, Y. Toyoshima, K. Chida, K. Kimura, H. Sakoda, A. Takenaka, T. Asano, S. Takahashi

    J Biol Chem   Vol. 285 ( No. 27 )   20915 - 25   2025.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Accumulated evidence indicates that oxidative stress causes and/or promotes insulin resistance; however, the mechanism by which this occurs is not fully understood. This study was undertaken to elucidate the molecular mechanism by which oxidative stress induced by paraquat impairs insulin-dependent glucose uptake in 3T3-L1 adipocytes. We confirmed that paraquat-induced oxidative stress decreased glucose transporter 4 (GLUT4) translocation to the cell surface, resulting in repression of insulin-dependent 2-deoxyglucose uptake. Under these conditions, oxidative stress did not affect insulin-dependent tyrosine phosphorylation of insulin receptor, insulin receptor substrate (IRS)-1 and -2, or binding of the phosphatidylinositol 3'-OH kinase (PI 3-kinase) p85 regulatory subunit or p110alpha catalytic subunit to each IRS. In contrast, we found that oxidative stress induced by paraquat inhibited activities of PI 3-kinase bound to IRSs and also inhibited phosphorylation of Akt, the downstream serine/threonine kinase that has been shown to play an essential role in insulin-dependent translocation of GLUT4 to the plasma membrane. Overexpression of active form Akt (myr-Akt) restored inhibition of insulin-dependent glucose uptake by paraquat, indicating that paraquat-induced oxidative stress inhibits insulin signals upstream of Akt. Paraquat treatment with and without insulin treatment decreased the activity of class Ia PI 3-kinases p110alpha and p110beta that are mainly expressed in 3T3-L1 adipocytes. However, paraquat treatment did not repress the activity of the PI 3-kinase p110alpha mutated at Cys(90) in the p85 binding region. These results indicate that the PI 3-kinase p110 is a possible primary target of paraquat-induced oxidative stress to reduce the PI 3-kinase activity and impaired glucose uptake in 3T3-L1 adipocytes.

    DOI: 10.1074/jbc.M110.126482

    PubMed

    researchmap

  • Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3', 5'-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells Reviewed International journal

    T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, S. Takahashi

    Endocrinology   Vol. 149 ( No. 7 )   3729 - 42   2025.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Bioactivities of IGFs in various cells are often potentiated in the presence of other hormones. In previous studies we showed that pretreatment of rat FRTL-5 thyroid cells with TSH or other cAMP-generating agents markedly potentiated DNA synthesis induced by IGF-I. Under these conditions we found that phosphatidylinositol (PI) 3-kinase was activated in response to either cAMP or IGF stimulus, and both activation modes were indispensable for the potentiation of DNA synthesis. The present studies were undertaken to elucidate how cAMP and/or IGF-I stimulus regulated the G1 cyclin-cyclin dependent kinase (CDK)-inhibitor system, and to determine the roles of PI 3-kinase activation by cAMP or IGF-I stimulus in this system. We found that cAMP pretreatment enhanced IGF-I-dependent increases in cyclin D1, due to synergistic increases in mRNA and elevation of translation rates. Furthermore, cAMP pretreatment enhanced IGF-I-induced protein degradation of the CDK inhibitor, p27(Kip1). These changes well explained an increase in cyclin E, leading to marked activation of G1 CDKs, followed by retinoblastoma protein phosphorylation. Our results using a PI 3-kinase inhibitor showed that cAMP-dependent PI 3-kinase activation plays an important role in the increase in cyclin D1 translation. In contrast, IGF-I-dependent PI 3-kinase activation was required for the increase in cyclin D1 mRNA levels and degradation of p27(Kip1). Together, the present study elucidates the role of cAMP and IGF-I in differentially activating PI 3-kinase as a mediator of multiple molecular events. These events converge in the regulation of cyclin D1 and p27(Kip1), leading to cAMP-dependent potentiation of IGF-I-dependent CDK activation and DNA synthesis.

    DOI: 10.1210/en.2007-1443

    PubMed

    researchmap

  • Apoptotic and non-apoptotic roles of caspases in placenta physiology and pathology. Reviewed International coauthorship International journal

    Lestari B, Fukushima T, Utomo RY, Wahyuningsih MSH

    Placenta   Vol. 151   37 - 47   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.placenta.2024.03.013

    researchmap

  • USP8の自己阻害機構の理解に基づく阻害剤開発とクッシング病治療への応用

    福嶋俊明

    2025.6

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Insulin/insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs Reviewed International journal

    H. Yoshihara, T. Fukushima, F. Hakuno, Y. Saeki, K. Tanaka, A. Ito, M. Yoshida, S. Iemura, T. Natsume, T. Asano, K. Chida, L. Girnita, S. Takahashi

    Biochem Biophys Res Commun   Vol. 423 ( No. 1 )   122 - 7   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin receptor substrates (IRSs) play central roles in insulin/insulin-like growth factor (IGF) signaling and mediate a variety of their bioactivities. IRSs are tyrosine-phosphorylated by activated insulin receptor/IGF-I receptor tyrosine kinase in response to insulin/IGF, and are recognized by signaling molecules possessing the SH2 domain such as phosphatidylinositol 3-kinase (PI3K), leading to the activation of downstream pathways. Recent studies have suggested that degradation of IRSs by the ubiquitin-proteasome pathway leads to impaired insulin/IGF signaling, but the precise mechanism underlying the process is still unclear. In this study, we identified deubiquitinating enzyme ubiquitin specific protease 7 (USP7) as an IRS-2-interacting protein and demonstrated that deubiquitinase activity of USP7 plays important roles in IRS-2 stabilization through the ubiquitin-proteasome pathway. In addition, insulin treatment dissociated USP7 from IRS-2, leading to degradation of IRS-2. This dissociation was prevented by treatment with LY294002, a PI3K inhibitor, indicating that insulin activation of the PI3K pathway leads to dissociation of IRS-2 from USP7 and IRS-2 degradation. We obtained similar results for IRS-1 in cells treated with insulin and for IRS-2 in cells treated with IGF-I. Taken together, this is the first report demonstrating that USP7 is an IRS-1/2 deubiquitinating enzyme forming a negative feedback loop in insulin/IGF signaling.

    DOI: 10.1016/j.bbrc.2012.05.093

    PubMed

    researchmap

  • Phosphatidylinositol 3-kinase-binding protein, PI3KAP/XB130, is required for cAMP-induced amplification of IGF mitogenic activity in FRTL-5 thyroid cells Reviewed International journal

    D. Yamanaka, T. Akama, T. Fukushima, T. Nedachi, C. Kawasaki, K. Chida, S. Minami, K. Suzuki, F. Hakuno, S. Takahashi

    Mol Endocrinol   Vol. 26 ( No. 6 )   1043 - 55   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We previously demonstrated that long-term pretreatment of rat FRTL-5 thyroid cells with TSH or cAMP-generating reagents potentiated IGF-I-dependent DNA synthesis. Under these conditions, cAMP treatment increased tyrosine phosphorylation of a 125-kDa protein (p125) and its association with a p85 regulatory subunit of phosphatidylinositol 3-kinase (p85 PI3K), which were suggested to mediate potentiation of DNA synthesis. This study was undertaken to identify p125 and to elucidate its roles in potentiation of DNA synthesis induced by IGF-I. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis revealed p125 to be a rat ortholog of human XB130, which we named PI3K-associated protein (PI3KAP). cAMP treatment elevated PI3KAP/XB130 mRNA and protein levels as well as tyrosine phosphorylation and interaction with p85 PI3K leading to increased PI3K activities associated with PI3KAP/XB130, supporting the role of PI3KAP/XB130 in DNA synthesis potentiation. Importantly, PI3KAP/XB130 knockdown attenuated cAMP-dependent potentiation of IGF-I-induced DNA synthesis. Furthermore, c-Src was associated with PI3KAP/XB130 and was activated in response to cAMP. Addition of Src family kinase inhibitors, PP1 or PP2, during cAMP treatment abolished tyrosine phosphorylation of PI3KAP/XB130 and its interaction with p85 PI3K. Finally, introduction of PI3KAP/XB130 into NIH3T3 fibroblasts lacking endogenous PI3KAP/XB130 enhanced IGF-I-induced DNA synthesis; however, a mutant Y72F incapable of binding to p85 PI3K did not show this response. Together, these data indicate that cAMP-dependent induction of PI3KAP/XB130, which is associated with PI3K, is required for enhancement of IGF mitogenic activities.

    DOI: 10.1210/me.2011-1349

    PubMed

    researchmap

  • Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis Reviewed International journal

    Y. Nakatsu, H. Sakoda, A. Kushiyama, J. Zhang, H. Ono, M. Fujishiro, T. Kikuchi, T. Fukushima, M. Yoneda, H. Ohno, N. Horike, M. Kanna, Y. Tsuchiya, H. Kamata, F. Nishimura, T. Isobe, T. Ogihara, H. Katagiri, Y. Oka, S. Takahashi, H. Kurihara, T. Uchida, T. Asano

    J Biol Chem   Vol. 286 ( No. 23 )   20812 - 22   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is a unique enzyme that associates with the pSer/Thr-Pro motif and catalyzes cis-trans isomerization. We identified Pin1 in the immunoprecipitates of overexpressed IRS-1 with myc and FLAG tags in mouse livers and confirmed the association between IRS-1 and Pin1 by not only overexpression experiments but also endogenously in the mouse liver. The analysis using deletion- and point-mutated Pin1 and IRS-1 constructs revealed the WW domain located in the N terminus of Pin1 and Ser-434 in the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 to be involved in their association. Subsequently, we investigated the role of Pin1 in IRS-1 mediation of insulin signaling. The overexpression of Pin1 in HepG2 cells markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events: phosphatidylinositol 3-kinase binding with IRS-1 and Akt phosphorylation. In contrast, the treatment of HepG2 cells with Pin1 siRNA or the Pin1 inhibitor Juglone suppressed these events. In good agreement with these in vitro data, Pin1 knock-out mice exhibited impaired insulin signaling with glucose intolerance, whereas adenoviral gene transfer of Pin1 into the ob/ob mouse liver mostly normalized insulin signaling and restored glucose tolerance. In addition, it was also demonstrated that Pin1 plays a critical role in adipose differentiation, making Pin1 knock-out mice resistant to diet-induced obesity. Importantly, Pin1 expression was shown to be up-regulated in accordance with nutrient conditions such as food intake or a high-fat diet. Taken together, these observations indicate that Pin1 binds to IRS-1 and thereby markedly enhances insulin action, essential for adipogenesis.

    DOI: 10.1074/jbc.M110.206904

    PubMed

    researchmap

  • Gag ubiquitination facilitates ALIX-mediated lentiviral RNA packaging, counteracted by USP8

    Kenta Hagiuda, Yuya Himi, Masayuki Komada, Toshiaki Fukushima

    2025.5

  • Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion Reviewed International journal

    K. Kawaguchi, A. Endo, T. Fukushima, Y. Madoka, T. Tanaka, M. Komada

    Biochem Biophys Res Commun   Vol. 499 ( No. 3 )   635 - 641   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nascent cargo proteins in the endoplasmic reticulum are transported to the Golgi by COPII carriers. Typical COPII vesicles are 60-70 nm in diameter, and much larger macromolecules, such as procollagen, are transported by atypical large COPII carriers in mammalian cells. The formation of large COPII carriers is enhanced by Cul3 ubiquitin ligase, which mono-ubiquitinates Sec31A, a COPII coat protein. However, the deubiquitinating enzyme for Sec31A was unclear. Here, we show that the deubiquitinating enzyme USP8 interacts with and deubiquitinates Sec31A. The interaction was mediated by the adaptor protein STAM1. USP8 overexpression inhibited the formation of large COPII carriers. By contrast, USP8 knockdown caused the accumulation of COPII coat proteins around the cis-Golgi, promoted the intracellular trafficking of procollagen IV from the endoplasmic reticulum to the Golgi, and increased collagen IV secretion. We concluded that USP8 deubiquitinates Sec31A and inhibits the formation of large COPII carriers, thereby suppressing collagen IV secretion.

    DOI: 10.1016/j.bbrc.2018.03.202

    PubMed

    researchmap

  • Integrator complex plays an essential role in adipose differentiation Reviewed International journal

    Y. Otani, Y. Nakatsu, H. Sakoda, T. Fukushima, M. Fujishiro, A. Kushiyama, H. Okubo, Y. Tsuchiya, H. Ohno, S. Takahashi, F. Nishimura, H. Kamata, H. Katagiri, T. Asano

    Biochem Biophys Res Commun   Vol. 434 ( No. 2 )   197 - 202   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The dynamic process of adipose differentiation involves stepwise expressions of transcription factors and proteins specific to the mature fat cell phenotype. In this study, it was revealed that expression levels of IntS6 and IntS11, subunits of the Integrator complex, were increased in 3T3-L1 cells in the period when the cells reached confluence and differentiated into adipocytes, while being reduced to basal levels after the completion of differentiation. Suppression of IntS6 or IntS11 expression using siRNAs in 3T3-L1 preadipocytes markedly inhibited differentiation into mature adipocytes, based on morphological findings as well as mRNA analysis of adipocyte-specific genes such as Glut4, perilipin and Fabp4. Although Pparγ2 protein expression was suppressed in IntS6 or IntS11-siRNA treated cells, adenoviral forced expression of Pparγ2 failed to restore the capacity for differentiation into mature adipocytes. Taken together, these findings demonstrate that increased expression of Integrator complex subunits is an indispensable event in adipose differentiation. Although further study is necessary to elucidate the underlying mechanism, the processing of U1, U2 small nuclear RNAs may be involved in cell differentiation steps.

    DOI: 10.1016/j.bbrc.2013.03.029

    PubMed

    researchmap

  • 4F2hc stabilizes GLUT1 protein and increases glucose transport activity Reviewed International journal

    H. Ohno, Y. Nakatsu, H. Sakoda, A. Kushiyama, H. Ono, M. Fujishiro, Y. Otani, H. Okubo, M. Yoneda, T. Fukushima, Y. Tsuchiya, H. Kamata, F. Nishimura, H. Kurihara, H. Katagiri, Y. Oka, T. Asano

    Am J Physiol Cell Physiol   Vol. 300 ( No. 5 )   C1047 - 54   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Glucose transporter 1 (GLUT1) is widely distributed throughout various tissues and contributes to insulin-independent basal glucose uptake. Using a split-ubiquitin membrane yeast two-hybrid system, we newly identified 4F2 heavy chain (4F2hc) as a membrane protein interacting with GLUT1. Though 4F2hc reportedly forms heterodimeric complexes between amino acid transporters, such as LAT1 and LAT2, and regulates amino acid uptake, we investigated the effects of 4F2hc on GLUT1 expression and the associated glucose uptake. First, FLAG-tagged 4F2hc and hemagglutinin-tagged GLUT1 were overexpressed in human embryonic kidney 293 cells and their association was confirmed by coimmunoprecipitation. The green fluorescent protein-tagged 4F2hc and DsRed-tagged GLUT1 showed significant, but incomplete, colocalization at the plasma membrane. In addition, an endogenous association between GLUT1 and 4F2hc was demonstrated using mouse brain tissue and HeLa cells. Interestingly, overexpression of 4F2hc increased the amount of GLUT1 protein in HeLa and HepG2 cells with increased glucose uptake. In contrast, small interfering RNA (siRNA)-mediated 4F2hc gene suppression markedly reduced GLUT1 protein in both cell types, with reduced glucose uptake. While GLUT1 mRNA levels were not affected by overexpression or gene silencing of 4F2hc, GLUT1 degradation after the addition of cycloheximide was significantly suppressed by 4F2hc overexpression and increased by 4F2hc siRNA treatment. Taken together, these observations indicate that 4F2hc is likely to be involved in GLUT1 stabilization and to contribute to the regulation of not only amino acid but also glucose metabolism.

    DOI: 10.1152/ajpcell.00416.2010

    PubMed

    researchmap

  • Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity Reviewed International journal

    T. Fukushima, H. Yoshihara, H. Furuta, H. Kamei, F. Hakuno, J. Luan, C. Duan, Y. Saeki, K. Tanaka, S. Iemura, T. Natsume, K. Chida, Y. Nakatsu, H. Kamata, T. Asano, S. Takahashi

    Nat Commun   Vol. 6   6780 - 6780   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin-like growth factors (IGFs) induce proliferation of various cell types and play important roles in somatic growth and cancer development. Phosphorylation of insulin receptor substrate (IRS)-1/2 by IGF-I receptor tyrosine kinase is essential for IGF action. Here we identify Nedd4 as an IRS-2 ubiquitin ligase. Nedd4 monoubiquitinates IRS-2, which promotes its association with Epsin1, a ubiquitin-binding protein. Nedd4 recruits IRS-2 to the membrane, probably through promoting Epsin1 binding, and enhances IGF-I receptor-induced IRS-2 tyrosine phosphorylation. In thyroid FRTL-5 cells, activation of the cyclic AMP pathway increases the association of Nedd4 with IRS-2, thereby enhancing IRS-2-mediated signalling and cell proliferation induced by IGF-I. The Nedd4 and IRS-2 association is also required for maximal activation of IGF-I signalling and cell proliferation in prostate cancer PC-3 cells. Nedd4 overexpression accelerates zebrafish embryonic growth through IRS-2 in vivo. We conclude that Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity.

    DOI: 10.1038/ncomms7780

    PubMed

    researchmap

  • USP8 prevents aberrant NF-κB and Nrf2 activation by counteracting ubiquitin signals from endosomes Reviewed International journal

    Akinori Endo, Toshiaki Fukushima, Chikage Takahashi, Hikaru Tsuchiya, Fumiaki Ohtake, Sayaka Ono, Tony Ly, Yukiko Yoshida, Keiji Tanaka, Yasushi Saeki, Masayuki Komada

    Journal of Cell Biology   Vol. 223 ( No. 3 )   e202306013   2025.3

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Rockefeller University Press  

    K63-linked ubiquitin chains attached to plasma membrane proteins serve as tags for endocytosis and endosome-to-lysosome sorting. USP8 is an essential deubiquitinase for the maintenance of endosomal functions. Prolonged depletion of USP8 leads to cell death, but the major effects on cellular signaling pathways are poorly understood. Here, we show that USP8 depletion causes aberrant accumulation of K63-linked ubiquitin chains on endosomes and induces immune and stress responses. Upon USP8 depletion, two different decoders for K63-linked ubiquitin chains, TAB2/3 and p62, were recruited to endosomes and activated the TAK1–NF-κB and Keap1–Nrf2 pathways, respectively. Oxidative stress, an environmental stimulus that potentially suppresses USP8 activity, induced accumulation of K63-linked ubiquitin chains on endosomes, recruitment of TAB2, and expression of the inflammatory cytokine. The results demonstrate that USP8 is a gatekeeper of misdirected ubiquitin signals and inhibits immune and stress response pathways by removing K63-linked ubiquitin chains from endosomes.

    DOI: 10.1083/jcb.202306013

    researchmap

  • 水溶性蛍光プローブの生細胞内における粘度応答性とメラノソームの可視化

    足立 惇弥, 小田 春佳, 福嶋 俊明, 菅井 祥加, 佐藤 浩平, 木村 宏, 金原 数

    2025.3

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Dense and Acidic Organelle-Targeted Visualization in Living Cells: Application of Viscosity-Responsive Fluorescence Utilizing Restricted Access to Minimum Energy Conical Intersection Reviewed International journal

    Junya Adachi, Haruka Oda, Toshiaki Fukushima, Beni Lestari, Hiroshi Kimura, Hiroka Sugai, Kentaro Shiraki, Rei Hamaguchi, Kohei Sato, Kazushi Kinbara

    Analytical Chemistry   95   5196–5204   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • クッシング病の治療薬開発を目指したUSP8-STAM1複合体を作用点とするACTH分泌制御物質の開発

    福嶋俊明, 遠藤彬則, 川口紘平, 円由香, 駒田雅之

    2025.3

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Nik-related kinase is targeted for proteasomal degradation by the chaperone-dependent ubiquitin ligase CHIP Reviewed International journal

    Satomi Naito, Toshiaki Fukushima, Akinori Endo, Kimitoshi Denda, Masayuki Komada

    FEBS Letters   594 ( 11 )   1778 - 1786   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nik-related kinase (Nrk) is a member of the germinal center kinase IV family and suppresses Akt signaling. In vivo, Nrk prevents placental hyperplasia and breast cancer formation. Here, we show that Nrk is regulated by the chaperone-dependent ubiquitin ligase carboxyl terminus of heat-shock protein (Hsp)70-interacting protein (CHIP). Immunoprecipitation and liquid chromatography-tandem mass spectrometry analysis reveal that Nrk preferentially interacts with CHIP and Hsp70/90 family proteins. Nrk protein levels are decreased by CHIP overexpression and increased by siRNA-mediated CHIP knockdown. Our results indicate that Nrk is ubiquitinated by CHIP in a chaperone-dependent manner, resulting in its proteasomal degradation. CHIP targets a fraction of Nrk molecules that have lost the ability to regulate Akt signaling. We conclude that CHIP plays an important role in regulating Nrk protein levels.

    DOI: 10.1002/1873-3468.13769

    PubMed

    researchmap

  • Glucose deprivation attenuates sortilin levels in skeletal muscle cells Reviewed International journal

    M. Ariga, Y. Yoneyama, T. Fukushima, Y. Ishiuchi, T. Ishii, H. Sato, F. Hakuno, T. Nedachi, S. I. Takahashi

    Endocr J   Vol. 64 ( No. 3 )   255 - 268   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In skeletal muscle, sortilin plays a predominant role in the sorting of glucose transporter 4 (Glut4), thereby controlling glucose uptake. Moreover, our previous study suggested that the sortilin expression levels are also implicated in myogenesis. Despite the importance of sortilin in skeletal muscle, however, the regulation of sortilin expression has not been completely understood. In the present study, we analyzed if the sortilin expression is regulated by glucose in C2C12 myocytes and rat skeletal muscles in vivo. Sortilin protein expression was elevated upon C2C12 cell differentiation and was further enhanced in the presence of a high concentration of glucose. The gene expression and protein degradation of sortilin were not affected by glucose. On the other hand, rapamycin partially reduced sortilin induction by a high concentration of glucose, which suggested that sortilin translation could be regulated by glucose, at least in part. We also examined if the sortilin regulation by glucose was also observed in skeletal muscles that were obtained from fed or fasted rats. Sortilin expression in both gastrocnemius and extensor digitorum longus (EDL) muscle was significantly decreased by 17-18h of starvation. On the other hand, pathological levels of high blood glucose did not alter the sortilin expression in rat skeletal muscle. Overall, the present study suggests that sortilin protein levels are reduced under hypoglycemic conditions by post-transcriptional control in skeletal muscles.

    DOI: 10.1507/endocrj.EJ16-0319

    PubMed

    researchmap

  • USP15 attenuates IGF-I signaling by antagonizing Nedd4-induced IRS-2 ubiquitination Reviewed International journal

    T. Fukushima, H. Yoshihara, H. Furuta, F. Hakuno, S. I. Iemura, T. Natsume, Y. Nakatsu, H. Kamata, T. Asano, M. Komada, S. I. Takahashi

    Biochem Biophys Res Commun   Vol. 484 ( No. 3 )   522 - 528   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin receptor substrates (IRSs) are phosphorylated by IGF-I receptor tyrosine kinase in a ligand-dependent manner. In turn, they bind to and activate effector proteins such as PI3K, leading to various cell responses including cell proliferation. We had reported that ubiquitin ligase Nedd4 induces mono-ubiquitination of IRS-2, thereby enhancing IRS-2 tyrosine phosphorylation, leading to increased IGF signaling and mitogenic activity. Here we show that ubiquitin-specific protease 15 (USP15) antagonizes the effect of Nedd4 on IRS-2. We identified USP15 as a protein that preferentially bound to IRS-2 when IRS-2 was conjugated with ubiquitin. In HEK293 cells, Nedd4 overexpression induced IRS-2 ubiquitination, which was decreased by USP15 co-expression while increased by USP15 knockdown. Nedd4 overexpression enhanced IGF-I-dependent IRS-2 tyrosine phosphorylation, and USP15 co-expression suppressed it. Conversely, USP15 knockdown increased IRS-2 tyrosine phosphorylation and downstream signaling in prostate cancer PC-3 cells. We concluded that USP15 attenuates IGF-I signaling by antagonizing Nedd4-induced IRS-2 ubiquitination.

    DOI: 10.1016/j.bbrc.2017.01.101

    PubMed

    researchmap

  • Insulin receptor substrate-1 associates with small nucleolar RNA which contributes to ribosome biogenesis Reviewed International journal

    A. Ozoe, M. Sone, T. Fukushima, N. Kataoka, K. Chida, T. Asano, F. Hakuno, S. Takahashi

    Front Endocrinol (Lausanne)   Vol. 5   24 - 24   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin receptor substrates (IRSs) are well known to play crucial roles in mediating intracellular signals of insulin-like growth factors (IGFs)/insulin. Previously, we showed that IRS-1 forms high molecular mass complexes containing RNAs. To identify RNAs in IRS-1 complexes, we performed ultraviolet (UV) cross-linking and immunoprecipitation analysis using HEK293 cells expressing FLAG-IRS-1 and FLAG-IRS-2. We detected the radioactive signals in the immunoprecipitates of FLAG-IRS-1 proportional to the UV irradiation, but not in the immunoprecipitates of FLAG-IRS-2, suggesting the direct contact of RNAs with IRS-1. RNAs cross-linked to IRS-1 were then amplified by RT-PCR, followed by sequence analysis. We isolated sequence tags attributed to 25 messenger RNAs and 8 non-coding RNAs, including small nucleolar RNAs (snoRNAs). We focused on the interaction of IRS-1 with U96A snoRNA (U96A) and its host Rack1 (receptor for activated C kinase 1) pre-mRNA. We confirmed the interaction of IRS-1 with U96A, and with RACK1 pre-mRNA by immunoprecipitation with IRS-1 followed by Northern blotting or RT-PCR analyses. Mature U96A in IRS-1(-/-) mouse embryonic fibroblasts was quantitatively less than WT. We also found that a part of nuclear IRS-1 is localized in the Cajal body, a nuclear subcompartment where snoRNA mature. The unanticipated function of IRS-1 in snoRNA biogenesis highlights the potential of RNA-associated IRS-1 complex to open a new line of investigation to dissect the novel mechanisms regulating IGFs/insulin-mediated biological events.

    DOI: 10.3389/fendo.2014.00024

    PubMed

    researchmap

  • ケモテクノロジーによって明らかとなった脱ユビキチン化酵素USP8の作用機構

    福嶋俊明

    2025.2

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development Reviewed International journal

    A. Kushiyama, H. Okubo, H. Sakoda, T. Kikuchi, M. Fujishiro, H. Sato, S. Kushiyama, M. Iwashita, F. Nishimura, T. Fukushima, Y. Nakatsu, H. Kamata, S. Kawazu, Y. Higashi, H. Kurihara, T. Asano

    Arterioscler Thromb Vasc Biol   Vol. 32 ( No. 2 )   291 - 8   2025.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Hyperuricemia is common in patients with metabolic syndrome. We investigated the role of xanthine oxidoreductase (XOR) in atherosclerosis development, and the effects of the XOR inhibitor allopurinol on this process. METHODS AND RESULTS: Oral administration of allopurinol to ApoE knockout mice markedly ameliorated lipid accumulation and calcification in the aorta and aortic root. In addition, allopurinol treatment or siRNA-mediated gene knockdown of XOR suppressed transformation of J774.1 murine macrophage cells, treated with acetylated LDL or very low density lipoprotein (VLDL) into foam cells. This inhibitory effect of allopurinol was also observed in primary cultured human macrophages. In contrast, overexpression of XOR promoted transformation of J774.1 cells into foam cells. Interestingly, SR-A1, SR-B1, SR-B II, and VLDL receptors in J774.1 cells were reduced by XOR knockdown, and increased by XOR overexpression. Conversely, expressions of ABCA1 and ABCG1 were increased by XOR knockdown and suppressed by XOR overexpression. Finally, productions of inflammatory cytokines accompanied by foam cell formation were also reduced by allopurinol administration. CONCLUSIONS: These results strongly suggest XOR activity and/or its expression level to contribute to macrophage foam cell formation. Thus, XOR inhibitors may be useful for preventing atherosclerosis.

    DOI: 10.1161/ATVBAHA.111.234559

    PubMed

    researchmap

  • 胎盤特異的な新規プロテインキナーゼNRKは乳腺組織における細胞増殖制御を司る

    伝田 公紀, 二口 充, 丹野 正隆, 福嶋 俊明, 田邉 暢子, 林 宣宏

    2025.1

     More details

    Language:Japanese   Publishing type:Research paper (conference, symposium, etc.)  

    researchmap

  • Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model Reviewed International journal

    H. Okubo, Y. Nakatsu, H. Sakoda, A. Kushiyama, M. Fujishiro, T. Fukushima, Y. Matsunaga, H. Ohno, M. Yoneda, H. Kamata, T. Shinjo, M. Iwashita, F. Nishimura, T. Asano

    Am J Physiol Gastrointest Liver Physiol   Vol. 308 ( No. 2 )   G151 - 8   2025.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Several lines of evidence have suggested a role of gut microbiota in the etiology of nonalcoholic steatohepatitis (NASH). NASH subjects reportedly showed a prolonged orocecal transit time coexistent with small intestinal bacterial overgrowth. We considered the possibility that enhanced gastrointestinal motility would influence gut microbiota and thus investigated the effects of the gastroprokinetic agent mosapride citrate (MC) on gut microbiota and the development of NASH using a methionine-choline deficient (MCD) diet-fed rodent model. Mice were divided into three groups, given the normal chow diet (NCD), the MCD diet, or the MCD diet containing 10 mg·kg(-1)·day(-1) of MC (MCD plus MC) for 6 wk. NASH development was evaluated based on hepatic histochemical findings, serum parameters and various mRNA and/or protein expression levels. MC treatment suppressed MCD diet-induced NASH development, with reduced serum lipopolysaccharide and increased plasma glucagon-like peptide-1 (GLP-1) concentrations. Calculation of the relative abundance of each strain based on gut microbiota analyses indicated lactic acid bacteria specifically, such as Bifidobacterium and Lactobacillus, in feces to be decreased in the MCD, compared with the NCD group. Interestingly, the reduction in lactic acid bacteria in the MCD diet group was reversed in the MCD plus MC group. In addition, colon inflammation observed in the MCD diet group was reduced in the MCD plus MC group. Therefore, MC showed a protective effect against MCD diet-induced NASH development in our rodent model, with possible involvements of increased fecal lactic acid bacteria, protection against colon inflammation and elevated plasma GLP-1.

    DOI: 10.1152/ajpgi.00198.2014

    PubMed

    researchmap

  • Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases Reviewed International journal

    T. Fukushima, T. Arai, M. Ariga-Nedachi, H. Okajima, Y. Ooi, Y. Iijima, M. Sone, Y. Cho, Y. Ando, K. Kasahara, A. Ozoe, H. Yoshihara, K. Chida, S. Okada, J. J. Kopchick, T. Asano, F. Hakuno, S. Takahashi

    Biochem Biophys Res Commun   Vol. 404 ( No. 3 )   767 - 73   2025.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin receptor substrates (IRSs) are phosphorylated by activated insulin/insulin-like growth factor (IGF)-I receptor tyrosine kinases. Phosphotyrosyl IRSs are recognized by signaling molecules possessing src homology region 2 (SH2) domains, which mediate various insulin/IGF bioactivities. However, we have shown that IRSs are also associated with other proteins by a phosphotyrosine-independent mechanism. Here, we demonstrated that IRSs form high-molecular-mass complexes (we named these complexes IRSomes) with various proteins and we elucidated their possible roles. Blue native-polyacrylamide gel electrophoresis of cell lysates revealed IRSome formation. Some proteins associated with IRSs in IRS-isoform-, cell-type-, or stimulus-specific manners. Results of the in vitro tyrosine phosphorylation assay indicated that tyrosine phosphorylation of IRS-1 by insulin receptor was decreased when IRS-1 was contained in IRSomes prepared from 3T3-L1 adipocytes treated with TNF-α. Also, tyrosine phosphorylation of IRS-2 by IGF-I receptor was increased when IRS-2 was contained in IRSomes prepared from FRTL-5 thyrocytes treated with dibutyryl cAMP. These results demonstrated that cytokine/hormone-induced formation of IRSomes modulates availability of IRSs to receptor tyrosine kinases.

    DOI: 10.1016/j.bbrc.2010.12.045

    PubMed

    researchmap

  • The placental protein NRK promotes cell death through its plasma membrane-localizing CNH domain

    Beni Lestari, Kohei Soda, Kei Moritsugu, Akinori Kidera, Yusuke Suenaga, Yoshitaka Hippo, Edy Meiyanto, Masayuki Komada, Mae Sri Hartati Wahyuningsih, Toshiaki Fukushima

    2023.12

  • Placental Mammals Acquired Functional Sequences in NRK for Regulating the CK2-PTEN-AKT Pathway and Placental Cell Proliferation. International journal

    Beni Lestari, Satomi Naito, Akinori Endo, Hidenori Nishihara, Akira Kato, Erika Watanabe, Kimitoshi Denda, Masayuki Komada, Toshiaki Fukushima

    Molecular biology and evolution   39 ( 2 )   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The molecular evolution processes underlying the acquisition of the placenta in eutherian ancestors are not fully understood. Mouse NCK-interacting kinase (NIK)-related kinase (NRK) is expressed highly in the placenta and plays a role in preventing placental hyperplasia. Here, we show the molecular evolution of NRK, which confers its function for inhibiting placental cell proliferation. Comparative genome analysis identified NRK orthologs across vertebrates, which share the kinase and citron homology (CNH) domains. Evolutionary analysis revealed that NRK underwent extensive amino acid substitutions in the ancestor of placental mammals and has been since conserved. Biochemical analysis of mouse NRK revealed that the CNH domain binds to phospholipids, and a region in NRK binds to and inhibits casein kinase-2 (CK2), which we named the CK2-inhibitory region (CIR). Cell culture experiments suggest the following: 1) Mouse NRK is localized at the plasma membrane via the CNH domain, where the CIR inhibits CK2. 2) This mitigates CK2-dependent phosphorylation and inhibition of PTEN and 3) leads to the inhibition of AKT signaling and cell proliferation. Nrk deficiency increased phosphorylation levels of PTEN and AKT in mouse placenta, supporting our hypothesis. Unlike mouse NRK, chicken NRK did not bind to phospholipids and CK2, decrease phosphorylation of AKT, or inhibit cell proliferation. Both the CNH domain and CIR have evolved under purifying selection in placental mammals. Taken together, our study suggests that placental mammals acquired the phospholipid-binding CNH domain and CIR in NRK for regulating the CK2-PTEN-AKT pathway and placental cell proliferation.

    DOI: 10.1093/molbev/msab371

    PubMed

    researchmap

  • Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain. International journal

    Keijun Kakihara, Kengo Asamizu, Kei Moritsugu, Masahide Kubo, Tetsuya Kitaguchi, Akinori Endo, Akinori Kidera, Mitsunori Ikeguchi, Akira Kato, Masayuki Komada, Toshiaki Fukushima

    Communications biology   4 ( 1 )   1272 - 1272   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ubiquitin-specific protease 8 (USP8) is a deubiquitinating enzyme involved in multiple membrane trafficking pathways. The enzyme activity is inhibited by binding to 14-3-3 proteins. Mutations in the 14-3-3-binding motif in USP8 are related to Cushing's disease. However, the molecular basis of USP8 activity regulation remains unclear. This study identified amino acids 645-684 of USP8 as an autoinhibitory region, which might interact with the catalytic USP domain, as per the results of pull-down and single-molecule FRET assays performed in this study. In silico modelling indicated that the region forms a WW-like domain structure, plugs the catalytic cleft, and narrows the entrance to the ubiquitin-binding pocket. Furthermore, 14-3-3 inhibited USP8 activity partly by enhancing the interaction between the WW-like and USP domains. These findings provide the molecular basis of USP8 autoinhibition via the WW-like domain. Moreover, they suggest that the release of autoinhibition may underlie Cushing's disease due to USP8 mutations.

    DOI: 10.1038/s42003-021-02802-x

    PubMed

    researchmap

  • Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy. International journal

    Vivien Béziat, Franck Rapaport, Jiafen Hu, Matthias Titeux, Mathilde Bonnet des Claustres, Mathieu Bourgey, Heather Griffin, Élise Bandet, Cindy S Ma, Roya Sherkat, Hassan Rokni-Zadeh, David M Louis, Majid Changi-Ashtiani, Ottavia M Delmonte, Toshiaki Fukushima, Tanwir Habib, Andrea Guennoun, Taushif Khan, Noemi Bender, Mahbuba Rahman, Frédégonde About, Rui Yang, Geetha Rao, Claire Rouzaud, Jingwei Li, Debra Shearer, Karla Balogh, Fatima Al Ali, Manar Ata, Soroosh Dabiri, Mana Momenilandi, Justine Nammour, Marie-Alexandra Alyanakian, Marianne Leruez-Ville, David Guenat, Marie Materna, Léa Marcot, Natasha Vladikine, Christine Soret, Hassan Vahidnezhad, Leila Youssefian, Amir Hossein Saeidian, Jouni Uitto, Émilie Catherinot, Shadi Sadat Navabi, Mohammed Zarhrate, David T Woodley, Mohamed Jeljeli, Thomas Abraham, Serkan Belkaya, Lazaro Lorenzo, Jérémie Rosain, Mousa Bayat, Fanny Lanternier, Olivier Lortholary, Faramarz Zakavi, Philippe Gros, Gérard Orth, Laurent Abel, Jean-Luc Prétet, Sylvie Fraitag, Emmanuelle Jouanguy, Mark M Davis, Stuart G Tangye, Luigi D Notarangelo, Nico Marr, Tim Waterboer, David Langlais, John Doorbar, Alain Hovnanian, Neil Christensen, Xavier Bossuyt, Mohammad Shahrooei, Jean-Laurent Casanova

    Cell   184 ( 14 )   3812 - 3828   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We study a patient with the human papilloma virus (HPV)-2-driven "tree-man" phenotype and two relatives with unusually severe HPV4-driven warts. The giant horns form an HPV-2-driven multifocal benign epithelial tumor overexpressing viral oncogenes in the epidermis basal layer. The patients are unexpectedly homozygous for a private CD28 variant. They have no detectable CD28 on their T cells, with the exception of a small contingent of revertant memory CD4+ T cells. T cell development is barely affected, and T cells respond to CD3 and CD2, but not CD28, costimulation. Although the patients do not display HPV-2- and HPV-4-reactive CD4+ T cells in vitro, they make antibodies specific for both viruses in vivo. CD28-deficient mice are susceptible to cutaneous infections with the mouse papillomavirus MmuPV1. The control of HPV-2 and HPV-4 in keratinocytes is dependent on the T cell CD28 co-activation pathway. Surprisingly, human CD28-dependent T cell responses are largely redundant for protective immunity.

    DOI: 10.1016/j.cell.2021.06.004

    PubMed

    researchmap

  • RNA-seq of Isolated Chromaffin Cells Highlights the Role of Sex-Linked and Imprinted Genes in Adrenal Medulla Development. International journal

    Wing Hei Chan, Masayuki Komada, Toshiaki Fukushima, E Michelle Southard-Smith, Colin R Anderson, Matthew J Wakefield

    Scientific reports   9 ( 1 )   3929 - 3929   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Adrenal chromaffin cells and sympathetic neurons synthesize and release catecholamines, and both cell types are derived from neural crest precursors. However, they have different developmental histories, with sympathetic neurons derived directly from neural crest precursors while adrenal chromaffin cells arise from neural crest-derived cells that express Schwann cell markers. We have sought to identify the genes, including imprinted genes, which regulate the development of the two cell types in mice. We developed a method of separating the two cell types as early as E12.5, using differences in expression of enhanced yellow fluorescent protein driven from the tyrosine hydroxylase gene, and then used RNA sequencing to confirm the characteristic molecular signatures of the two cell types. We identified genes differentially expressed by adrenal chromaffin cells and sympathetic neurons. Deletion of a gene highly expressed by adrenal chromaffin cells, NIK-related kinase, a gene on the X-chromosome, results in reduced expression of adrenaline-synthesizing enzyme, phenyl-N-methyl transferase, by adrenal chromaffin cells and changes in cell cycle dynamics. Finally, many imprinted genes are up-regulated in chromaffin cells and may play key roles in their development.

    DOI: 10.1038/s41598-019-40501-0

    PubMed

    researchmap

  • The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors. International journal

    Ryohei Sakai, Ryosuke Fukuda, Shin Unida, Misaki Aki, Yuji Ono, Akinori Endo, Satoshi Kusumi, Daisuke Koga, Toshiaki Fukushima, Masayuki Komada, Tsukasa Okiyoneda

    Journal of cell science   132 ( 3 )   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Endocytic trafficking is regulated by ubiquitylation (also known as ubiquitination) of cargoes and endocytic machineries. The role of ubiquitylation in lysosomal delivery has been well documented, but its role in the recycling pathway is largely unknown. Here, we report that the ubiquitin (Ub) ligase RFFL regulates ubiquitylation of endocytic recycling regulators. An RFFL dominant-negative (DN) mutant induced clustering of endocytic recycling compartments (ERCs) and delayed endocytic cargo recycling without affecting lysosomal traffic. A BioID RFFL interactome analysis revealed that RFFL interacts with the Rab11 effectors EHD1, MICALL1 and class I Rab11-FIPs. The RFFL DN mutant strongly captured these Rab11 effectors and inhibited their ubiquitylation. The prolonged interaction of RFFL with Rab11 effectors was sufficient to induce the clustered ERC phenotype and to delay cargo recycling. RFFL directly ubiquitylates these Rab11 effectors in vitro, but RFFL knockout (KO) only reduced the ubiquitylation of Rab11-FIP1. RFFL KO had a minimal effect on the ubiquitylation of EHD1, MICALL1, and Rab11-FIP2, and failed to delay transferrin recycling. These results suggest that multiple Ub ligases including RFFL regulate the ubiquitylation of Rab11 effectors, determining the integral function of the ERC.

    DOI: 10.1242/jcs.228007

    PubMed

    researchmap

  • IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line. International journal

    Haruka Furuta, Hidehito Yoshihara, Toshiaki Fukushima, Yosuke Yoneyama, Akihiro Ito, Claire Worrall, Ada Girnita, Leonard Girnita, Minoru Yoshida, Tomoichiro Asano, Masayuki Komada, Naoyuki Kataoka, Kazuhiro Chida, Fumihiko Hakuno, Shin-Ichiro Takahashi

    Oncotarget   9 ( 74 )   33871 - 33883   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin-like growth factors (IGFs) have been shown to induce proliferation of many types of cells. Insulin receptor substrates (IRSs) are major targets of IGF-I receptor (IGF-IR) tyrosine kinase activated by IGFs, and are known to play important roles in the activation of downstream signaling pathways, such as the Erk1/2 pathway. Dysregulation of IGF signaling represents a central tumor promoting principle in human carcinogenesis. Prostate carcinoma is highly dependent on the IGF/IGF-IR/IRS axis. Here we identified the deubiquitinase, ubiquitin specific peptidase 9X (USP9X) as a novel binding partner of IRS-2. In a human prostate carcinoma cell line, small interfering RNA (siRNA)-mediated knockdown of USP9X reduced IGF-IR as well as IRS-2 protein levels and increased their ubiquitination. Knockdown of USP9X suppressed basal activation of the Erk1/2 pathway, which was significantly restored by exogenous expression of IRS-2 but not by IGF-IR, suggesting that the stabilization of IRS-2 by USP9X is critical for basal Erk1/2 activation. Finally, we measured anchorage-independent cell growth, a characteristic cancer feature, by soft-agar colony formation assay. Knockdown of USP9X significantly reduced anchorage-independent cell growth of prostate carcinoma cell line. Taken all together, our findings indicate that USP9X is required for the promotion of prostate cancer growth by maintaining the activation of the Erk1/2 pathway through IRS-2 stabilization.

    DOI: 10.18632/oncotarget.26049

    PubMed

    researchmap

  • Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities. International journal

    Xuan Xie, Shunsuke Matsumoto, Akinori Endo, Toshiaki Fukushima, Hiroyuki Kawahara, Yasushi Saeki, Masayuki Komada

    Journal of cell science   131 ( 8 )   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Stress granules are transient cytoplasmic foci induced by various stresses that contain translation-stalled mRNAs and RNA-binding proteins. They are proposed to modulate mRNA translation and stress responses. Here, we show that the deubiquitylases USP5 and USP13 are recruited to heat-induced stress granules. Heat-induced stress granules also contained K48- and K63-linked ubiquitin chains. Depletion of USP5 or USP13 resulted in elevated ubiquitin chain levels and accelerated assembly of heat-induced stress granules, suggesting that these enzymes regulate the stability of the stress granules through their ubiquitin isopeptidase activity. Moreover, disassembly of heat-induced stress granules after returning the cells to normal temperatures was markedly repressed by individual depletion of USP5 or USP13. Finally, overexpression of a ubiquitin mutant lacking the C-terminal diglycine motif caused the accumulation of unanchored ubiquitin chains and the repression of the disassembly of heat-induced stress granules. As unanchored ubiquitin chains are preferred substrates for USP5, we suggest that USP5 regulates the assembly and disassembly of heat-induced stress granules by mediating the hydrolysis of unanchored ubiquitin chains while USP13 regulates stress granules through deubiquitylating protein-conjugated ubiquitin chains.This article has an associated First Person interview with the first author of the paper.

    DOI: 10.1242/jcs.210856

    PubMed

    researchmap

  • Reduced SHARPIN and LUBAC Formation May Contribute to CCl₄- or Acetaminophen-Induced Liver Cirrhosis in Mice. International journal

    Takeshi Yamamotoya, Yusuke Nakatsu, Yasuka Matsunaga, Toshiaki Fukushima, Hiroki Yamazaki, Sunao Kaneko, Midori Fujishiro, Takako Kikuchi, Akifumi Kushiyama, Fuminori Tokunaga, Tomoichiro Asano, Hideyuki Sakoda

    International journal of molecular sciences   18 ( 2 )   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Linear ubiquitin chain assembly complex (LUBAC), composed of SHARPIN (SHANK-associated RH domain-interacting protein), HOIL-1L (longer isoform of heme-oxidized iron-regulatory protein 2 ubiquitin ligase-1), and HOIP (HOIL-1L interacting protein), forms linear ubiquitin on nuclear factor-κB (NF-κB) essential modulator (NEMO) and induces NF-κB pathway activation. SHARPIN expression and LUBAC formation were significantly reduced in the livers of mice 24 h after the injection of either carbon tetrachloride (CCl₄) or acetaminophen (APAP), both of which produced the fulminant hepatitis phenotype. To elucidate its pathological significance, hepatic SHARPIN expression was suppressed in mice by injecting shRNA adenovirus via the tail vein. Seven days after this transduction, without additional inflammatory stimuli, substantial inflammation and fibrosis with enhanced hepatocyte apoptosis occurred in the livers. A similar but more severe phenotype was observed with suppression of HOIP, which is responsible for the E3 ligase activity of LUBAC. Furthermore, in good agreement with these in vivo results, transduction of Hepa1-6 hepatoma cells with SHARPIN, HOIL-1L, or HOIP shRNA adenovirus induced apoptosis of these cells in response to tumor necrosis factor-α (TNFα) stimulation. Thus, LUBAC is essential for the survival of hepatocytes, and it is likely that reduction of LUBAC is a factor promoting hepatocyte death in addition to the direct effect of drug toxicity.

    DOI: 10.3390/ijms18020326

    PubMed

    researchmap

  • Involvement of resistin-like molecule beta in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice Reviewed International journal

    H. Okubo, A. Kushiyama, H. Sakoda, Y. Nakatsu, M. Iizuka, N. Taki, M. Fujishiro, T. Fukushima, H. Kamata, A. Nagamachi, T. Inaba, F. Nishimura, H. Katagiri, T. Asahara, Y. Yoshida, O. Chonan, J. Encinas, T. Asano

    Sci Rep   Vol. 6   20157 - 20157   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Resistin-like molecule β (RELMβ) reportedly has multiple functions including local immune responses in the gut. In this study, we investigated the possible contribution of RELMβ to non-alcoholic steatohepatitis (NASH) development. First, RELMβ knock-out (KO) mice were shown to be resistant to methionine-choline deficient (MCD) diet-induced NASH development. Since it was newly revealed that Kupffer cells in the liver express RELMβ and that RELMβ expression levels in the colon and the numbers of RELMβ-positive Kupffer cells were both increased in this model, we carried out further experiments using radiation chimeras between wild-type and RELMβ-KO mice to distinguish between the contributions of RELMβ in these two organs. These experiments revealed the requirement of RELMβ in both organs for full manifestation of NASH, while deletion of each one alone attenuated the development of NASH with reduced serum lipopolysaccharide (LPS) levels. The higher proportion of lactic acid bacteria in the gut microbiota of RELMβ-KO than in that of wild-type mice may be one of the mechanisms underlying the lower serum LPS level the former. These data suggest the contribution of increases in RELMβ in the gut and Kupffer cells to NASH development, raising the possibility of RELMβ being a novel therapeutic target for NASH.

    DOI: 10.1038/srep20157

    PubMed

    researchmap

  • When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling

    L. Girnita, S. -I. Takahashi, C. Crudden, T. Fukushima, C. Worrall, H. Furuta, H. Yoshihara, F. Hakuno, A. Girnita

    UBIQUITINATION AND TRANSMEMBRANE SIGNALING   141   277 - 311   2016

     More details

    Language:English   Publishing type:Part of collection (book)  

    DOI: 10.1016/bs.pmbts.2016.04.001

    Web of Science

    researchmap

  • 非アルコール性脂肪性肝炎におけるLUBAC形成障害の解析

    松永 泰花, 中津 祐介, 福嶋 俊明, 大久保 博史, 岩下 未咲, 迫田 秀之, 藤城 緑, 山本屋 武, 櫛山 暁史, 高橋 伸一郎, 土谷 佳弘, 鎌田 英明, 徳永 文稔, 岩井 一宏, 浅野 知一郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [4T特 - 04(3P1180)]   2015.12

     More details

    Language:English   Publisher:(公社)日本生化学会  

    researchmap

  • DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation. International journal

    Takanori Shinjo, Yusuke Nakatsu, Misaki Iwashita, Tomomi Sano, Hideyuki Sakoda, Hisamitsu Ishihara, Akifumi Kushiyama, Midori Fujishiro, Toshiaki Fukushima, Yoshihiro Tsuchiya, Hideaki Kamata, Fusanori Nishimura, Tomoichiro Asano

    American journal of physiology. Endocrinology and metabolism   309 ( 3 )   E214-23   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Dipeptidyl peptidase IV (DPP-IV) expression in visceral adipose tissue is reportedly increased in obese patients, suggesting an association of DPP-IV with inflammation. In this study, first, lipopolysaccharide (LPS)- or palmitate-induced elevations of inflammatory cytokine mRNA expressions in RAW264.7 macrophages were shown to be significantly suppressed by coincubation with a DPP-IV inhibitor, anagliptin (10 μM), despite low DPP-IV expression in the RAW264.7 cells. Regarding the molecular mechanism, LPS-induced degradation of IκBα and phosphorylations of p65, JNK, and p38, as well as NF-κB and AP-1 promoter activities, were revealed to be suppressed by incubation with anagliptin, indicating suppressive effects of anagliptin on both NF-κB and AP-1 signaling pathways. Anagliptin also acted on 3T3-L1 adipocytes, weakly suppressing the inflammatory cytokine expressions induced by LPS and TNFα. When 3T3-L1 and RAW cells were cocultured and stimulated with LPS, the effects of anagliptin on the suppression of cytokine expressions in 3T3-L1 adipocytes were more marked and became evident at the 10 μM concentration. Anti-inflammatory effects of anagliptin were also observed in vivo on the elevated hepatic and adipose expressions and serum concentrations of inflammatory cytokines in association with the suppression of hepatic NF-κB transcriptional activity in LPS-infused mice. Taking these observations together, the anti-inflammatory properties of anagliptin may be beneficial in terms of preventing exacerbation of diabetes and cardiovascular events.

    DOI: 10.1152/ajpendo.00553.2014

    PubMed

    researchmap

  • The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. International journal

    Yusuke Nakatsu, Yasuyuki Seno, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Aya Katasako, Keiichi Mori, Yasuka Matsunaga, Toshiaki Fukushima, Ryuhei Kanaoka, Takeshi Yamamotoya, Hideaki Kamata, Tomoichiro Asano

    American journal of physiology. Gastrointestinal and liver physiology   309 ( 1 )   G42-51   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Xanthine oxidase (XO) is an enzyme involved in the production of uric acid (UA) from purine nucleotides. Numerous recent studies have revealed the likelihood of metabolic syndrome including nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH) to be related to hyperuricemia. However, it remains unclear whether elevated serum UA during the development of NAFLD or NASH is a cause or a consequence of these diseases. In this study, the XO inhibitor febuxostat was administered to two types of NASH model mice. Febuxostat exerted a strong protective effect against NASH development induced by a high-fat diet containing trans fatty acid (HFDT). In contrast, methionine choline-deficient-diet-induced NASH development not accompanied by hyperuricemia showed no UA normalization, suggesting that the ameliorating effect of febuxostat occurs via the normalization of hyperuricemia itself and/or accompanying molecular mechanism(s) such as oxidative stress. In the HFDT-fed mice, hyperuricemia, elevated alanine aminotransferase, and increased Tunnel-positive cells in the liver were normalized by febuxostat administration. In addition, upregulation of fatty acid oxidation-related genes, fibrotic change, and increases in collagen deposition, inflammatory cytokine expressions, and lipid peroxidation in the HFDT-fed mice were also normalized by febuxostat administration. Taken together, these observations indicate that administration of febuxostat has a protective effect against HFDT-induced NASH development, suggesting the importance of XO in its pathogenesis. Thus XO inhibitors are potentially potent therapies for patients with NASH, particularly that associated with hyperuricemia.

    DOI: 10.1152/ajpgi.00443.2014

    PubMed

    researchmap

  • Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines Reviewed International journal

    R. Kanaoka, A. Kushiyama, Y. Seno, Y. Nakatsu, Y. Matsunaga, T. Fukushima, Y. Tsuchiya, H. Sakoda, M. Fujishiro, T. Yamamotoya, H. Kamata, A. Matsubara, T. Asano

    PLoS One   Vol. 10 ( No. 6 )   e0127467   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Prostate cancer initially develops in an androgen-dependent manner but, during its progression, transitions to being androgen-independent in the advanced stage. Pin1, one of the peptidyl-prolyl cis/trans isomerases, is reportedly overexpressed in prostate cancers and is considered to contribute to accelerated cell growth, which may be one of the major factors contributing to their androgen-independent growth. Thus, we investigated how Pin1 modulates the gene expressions in both androgen-dependent and androgen-independent prostate cancer cell lines using microarray analysis. In addition, the effects of Juglone, a commercially available Pin1 inhibitor were also examined. METHODS: Two prostate cancer cell-lines, LNCaP (androgen-dependent) and DU145 (androgen-independent), were treated with Pin1 siRNA and its effects on gene expressions were analyzed by microarray. Individual gene regulations induced by Pin1 siRNA or the Pin1 inhibitor Juglone were examined using RT-PCR. In addition, the effects of Juglone on the growth of LNCaP and DU145 transplanted into mice were investigated. RESULTS: Microarray analysis revealed that transcriptional factors regulated by Pin1 differed markedly between LNCaP and DU145 cells, the only exception being that Nrf was regulated in the same way by Pin1 siRNA in both cell lines. Despite this marked difference in gene regulations, Pin1 siRNA and Juglone exert a strong inhibitory effect on both the LNCaP and the DU145 cell line, suppressing in vitro cell proliferation as well as tumor enlargement when transplanted into mice. CONCLUSIONS: Despite Pin1-regulated gene expressions differing between these two prostate cancer cell-lines, LNCaP (androgen-dependent) and DU145 (androgen-independent), Pin1 inhibition suppresses proliferation of both cell-lines. These findings suggest the potential effectiveness of Pin1 inhibitors as therapeutic agents for prostate cancers, regardless of their androgen sensitivity.

    DOI: 10.1371/journal.pone.0127467

    PubMed

    researchmap

  • LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis Reviewed International journal

    Y. Matsunaga, Y. Nakatsu, T. Fukushima, H. Okubo, M. Iwashita, H. Sakoda, M. Fujishiro, T. Yamamotoya, A. Kushiyama, S. Takahashi, Y. Tsuchiya, H. Kamata, F. Tokunaga, K. Iwai, T. Asano

    Mediators Inflamm   Vol. 2015   125380 - 125380   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nonalcoholic steatohepatitis (NASH) is a disorder characterized by hepatic lipid accumulation followed by the inflammation-induced death of hepatocytes and fibrosis. In this process, oxidative stress contributes to the induction of several inflammatory cytokines including TNF-α andIL-1β in macrophages, while, in hepatocytes, NF-κB reportedly induces the expressions of cell survival genes for protection from apoptosis. Recently, it was reported that the new ubiquitin ligase complex termed linear ubiquitin chain assembly complex (LUBAC), composed of SHARPIN (SHANK-associated RH domain-interacting protein), HOIL-1L (longer isoform of heme-oxidized iron-regulatory protein 2 ubiquitin ligase-1), and HOIP (HOIL-1L interacting protein), forms linear ubiquitin on NF-κB essential modulator (NEMO) and thereby induces NF-κB pathway activation. In this study, we demonstrated the formation of LUBAC to be impaired in the livers of NASH rodent models produced by methionine and choline deficient (MCD) diet feeding, first by either gel filtration or Blue Native-PAGE, with subsequent confirmation by western blotting. The reduction of LUBAC is likely to be attributable to markedly reduced expression of SHARPIN, one of its components. Thus, impaired LUBAC formation, which would result in insufficient NF-κB activation, may be one of the molecular mechanisms underlying the enhanced apoptotic response of hepatocytes in MCD diet-induced NASH livers.

    DOI: 10.1155/2015/125380

    PubMed

    researchmap

  • The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins Reviewed International journal

    F. Hakuno, T. Fukushima, Y. Yoneyama, H. Kamei, A. Ozoe, H. Yoshihara, D. Yamanaka, T. Shibano, M. Sone-Yonezawa, B. C. Yu, K. Chida, S. Takahashi

    Front Endocrinol (Lausanne)   Vol. 6   73 - 73   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Insulin-like peptides, such as insulin-like growth factors (IGFs) and insulin, induce a variety of bioactivities, such as growth, differentiation, survival, increased anabolism, and decreased catabolism in many cell types and in vivo. In general, IGFs or insulin bind to IGF-I receptor (IGF-IR) or insulin receptor (IR), activating the receptor tyrosine kinase. Insulin receptor substrates (IRSs) are known to be major substrates of receptor kinases, mediating IGF/insulin signals to direct bioactivities. Recently, we discovered that IRSs form high-molecular-mass complexes (referred to here as IRSomes) even without IGF/insulin stimulation. These complexes contain proteins (referred to here as IRSAPs; IRS-associated proteins), which modulate tyrosine phosphorylation of IRSs by receptor kinases, control IRS stability, and determine intracellular localization of IRSs. In addition, in these complexes, we found not only proteins that are involved in RNA metabolism but also RNAs themselves. Thus, IRSAPs possibly contribute to modulation of IGF/insulin bioactivities. Since it is established that disorder of modulation of insulin-like activities causes various age-related diseases including cancer, we could propose that the IRSome is an important target for treatment of these diseases.

    DOI: 10.3389/fendo.2015.00073

    PubMed

    researchmap

  • プロリン異性化酵素Pin1はAMPK γ subunitに結合し、活性を抑制する

    山崎 広貴, 中津 祐介, 岩下 未咲, 福嶋 俊明, 菊池 貴子, 櫛山 暁史, 藤城 緑, 迫田 秀之, 浅野 知一郎, 門脇 孝

    肥満研究   20 ( Suppl. )   196 - 196   2014.10

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

  • 非アルコール性脂肪肝炎発症におけるLUBAC形成障害の役割

    松永 泰花, 中津 祐介, 鎌田 英明, 福嶋 俊明, 岩下 未咲, 新城 尊徳, 菊池 貴子, 藤城 緑, 浅野 知一郎

    糖尿病   57 ( Suppl.1 )   S - 465   2014.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    researchmap

  • Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice. International journal

    Misaki Iwashita, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama, Toshiaki Fukushima, Sonoko Kumamoto, Takanori Shinjo, Hideaki Kamata, Fusanori Nishimura, Tomoichiro Asano

    Adipocyte   2 ( 1 )   28 - 32   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Inflammation involving adipose tissue is regarded as one of the major molecular mechanisms underlying obesity-related insulin resistance. Recent studies have suggested a series of angiotensin II receptor blockers (ARBs) to improve insulin resistance or protect against the development of diabetes mellitus. We previously demonstrated that valsartan suppresses the inflammatory response of macrophages. Interestingly, however, this effect did not occur via peroxisome proliferator-activated receptor (PPAR) γ or the AT1a receptor. This suppression appears to secondarily lead to amelioration of insulin resistance and reductions in abnormal gene expressions in adipocytes. In addition to these in vitro findings, we herein demonstrate the in vivo effects of valsartan, using mice constitutively infused with lipopolysaccharide (LPS) for 4 weeks. Oral administration of valsartan to LPS-infused mice normalized the increased expressions of inflammatory cytokines in adipose and liver tissues. These results raise the possibility that valsartan not only contributes to normalization of obesity-related insulin resistance, but is also beneficial for the treatment of other diseases with inflammation related to the metabolic syndrome such as atherosclerosis and non-alcoholic steatohepatitis. Further study is necessary to clarify these issues.

    PubMed

    researchmap

  • Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes. International journal

    Misaki Iwashita, Hideyuki Sakoda, Akifumi Kushiyama, Midori Fujishiro, Haruya Ohno, Yusuke Nakatsu, Toshiaki Fukushima, Sonoko Kumamoto, Yoshihiro Tsuchiya, Takako Kikuchi, Hiroki Kurihara, Hiroshi Akazawa, Issei Komuro, Hideaki Kamata, Fusanori Nishimura, Tomoichiro Asano

    American journal of physiology. Endocrinology and metabolism   302 ( 3 )   E286-96   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Macrophages are integrated into adipose tissues and interact with adipocytes in obese subjects, thereby exacerbating adipose insulin resistance. This study aimed to elucidate the molecular mechanism underlying the insulin-sensitizing effect of the angiotensin II receptor blocker (ARB) valsartan, as demonstrated in clinical studies. Insulin signaling, i.e., insulin receptor substrate-1 and Akt phosphorylations, in 3T3-L1 adipocytes was impaired markedly by treatment with tumor necrosis factor-α (TNFα) or in the culture medium of lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages, and valsartan had no effects on these impairments. However, in contrast, when cocultured with RAW 264.7 cells using a transwell system, the LPS-induced insulin signaling impairment in 3T3-L1 adipocytes showed almost complete normalization with coaddition of valsartan. Furthermore, valsartan strongly suppressed LPS-induced productions of cytokines such as interleukin (IL)-1β, IL-6, and TNFα with nuclear factor-κB activation and c-Jun NH(2)-terminal kinase phosphorylation in RAW 264.7 and primary murine macrophages. Very interestingly, this effect of valsartan was also observed in THP-1 cells treated with angiotensin II type 1 (AT1) siRNA or a peroxisome proliferator-activated receptor-γ (PPARγ) antagonist as well as macrophages from AT1a receptor-knockout mice. We conclude that valsartan suppresses the inflammatory response of macrophages, albeit not via PPARγ or the AT1a receptor. This suppression appears to secondarily improve adipose insulin resistance.

    DOI: 10.1152/ajpendo.00324.2011

    PubMed

    researchmap

  • IGF-I受容体内在化低下によりSGA性低身長を呈したIGF-I受容体遺伝子異常症の1家系

    鞁嶋 有紀, 宮原 直樹, 西村 玲, 長石 純一, 花木 啓一, 福嶋 俊明, 檜垣 克美, 高橋 伸一郎, 神崎 晋

    日本小児科学会雑誌   114 ( 2 )   255 - 255   2010.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. International journal

    Yuki Kawashima, Susumu Kanzaki, Fan Yang, Tomoe Kinoshita, Keiichi Hanaki, Jun-Ichi Nagaishi, Yoshihiko Ohtsuka, Ichirou Hisatome, Haruaki Ninomoya, Eiji Nanba, Toshiaki Fukushima, Shin-Ichiro Takahashi

    The Journal of clinical endocrinology and metabolism   90 ( 8 )   4679 - 87   2005.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    CONTEXT: Mouse knockout models have clearly demonstrated the critical importance of IGF-I and IGF receptor type 1 (IGF-IR) for embryonic growth as well as postnatal growth. OBJECTIVE: We hypothesized that mutations of IGF-IR gene might predispose to short stature in children born with intrauterine growth retardation (IUGR). PATIENTS: Twenty-four children with unexplained IUGR (birth weight < -1.5 SD) and short stature (<-2.0 SD) were screened for abnormalities of the IGF-IR gene. METHODS: Direct DNA sequencing was used to identify IGF-IR gene mutations. Unprocessed IGF-IR proreceptor in fibroblasts was detected by immunoblot analysis. Functions of mutated IGF-IR in fibroblasts were evaluated by IGF-I binding, and IGF-I-stimulated DNA synthesis and beta-subunit autophosphorylation. RESULTS: We found the following results: 1) a heterozygous mutation (R709Q) changing the cleavage site from Arg-Lys-Arg-Arg to Arg-Lys-Gln-Arg was identified in a 6-yr-old Japanese girl (case 1) and her mother who also had IUGR with short stature (case 2); 2) fibroblasts from case 2 contained more IGF-IR proreceptor protein (189 +/- 26% of normal) and less mature beta-subunit protein (63 +/- 12%); 3) [125I]IGF-I binding to fibroblasts from case 2 was reduced, compared with normal control (0.61 +/- 0.16 x 10(6) vs. 1.14 +/- 0.12 x 10(6) sites per cell; P < 0.05); and 4) both IGF-I-stimulated [3H]thymidine incorporation and IGF-IR beta-subunit autophosphorylation were low in fibroblasts from case 2, compared with those of control (P < 0.05). CONCLUSIONS: These findings strongly suggest that this mutation leads to failure of processing of the IGF-IR proreceptor to mature IGF-IR and causes short stature and IUGR.

    PubMed

    researchmap

  • Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. International journal

    Yumiko Okubo, Ken Siddle, Helen Firth, Steve O'Rahilly, Louise C Wilson, Lionel Willatt, Toshiaki Fukushima, Shin-ichiro Takahashi, Clive J Petry, Tero Saukkonen, Richard Stanhope, David B Dunger

    The Journal of clinical endocrinology and metabolism   88 ( 12 )   5981 - 8   2003.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The type 1 IGF receptor (IGF1R) is required for normal embryonic and postnatal growth. The aim of this study was to determine whether we could detect abnormal IGF1R function in skin fibroblasts from children with an abnormal copy number of the IGF1R gene. We report two children with altered copy number of the IGF1R gene who presented with abnormal growth. Case 1 is a girl with intrauterine growth retardation, postnatal growth failure, and recurrent hypoglycemia. Pituitary function tests were normal. Routine karyotype analysis identified a deletion on 15q26.2, and a fluorescence in situ hybridization study using IGF1R probes showed only a single IGF1R gene. Case 2 was large for gestational age, with birth weight and length at or above 97th percentile, and showed rapid early postnatal growth. He was found to have a recombinant chromosome 15 containing a partial duplication at 15q (q25-qter). A fluorescence in situ hybridization study using the same probes showed three copies of the IGF1R gene. In a mitochondrial activity assay, skin fibroblasts from the subject with only one copy of IGF1R showed slower growth, whereas cells from the subject with three copies of IGF1R showed accelerated growth compared with controls. IGF1R phosphorylation, as assessed by Western blot, and IGF1R binding studies were decreased compared with controls in the child with one copy of the IGF1R and increased in the child with three copies of the gene. Our data are consistent with the concept that IGF1R gene copy number is of functional and clinical importance in humans.

    PubMed

    researchmap

  • Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells

    Shin-Ichiro Takahashi, Taku Nedachi, Toshiaki Fukushima, Kota Umesaki, Yoshiaki Ito, Fumihiko Hakuno, Judson J. Van Wyk, Marco Conti

    Biochimica et Biophysica Acta - Molecular Cell Research   1540 ( 1 )   68 - 81   2001.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0167-4889(01)00119-7

    Scopus

    PubMed

    researchmap

▼display all

MISC

  • コラーゲンの細胞内輸送の分子機構 -脱ユビキチン化酵素USP8による輸送制御-

    福嶋俊明, 川口紘平

    FRAGRANCE JOURNAL   8   2020

     More details

  • Cushing病で見られる変異型脱ユビキチン化酵素USP8が核内で果たす役割の解明

    猪子和也, 澤田崇広, 遠藤彬則, 佐伯泰, 田中啓二, IBRAHIM Ardisasmita, 福嶋俊明, 福嶋俊明, 駒田雅之, 駒田雅之

    日本生化学会大会(Web)   90th   ROMBUNNO.3LBA‐030 (WEB ONLY) - 030]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    J-GLOBAL

    researchmap

  • 甲状腺細胞の増殖誘導機構

    高橋伸一郎, 福嶋俊明, 山中大介, 伯野史彦

    日本甲状腺学会雑誌   7 ( 1 )   2016

     More details

  • High-molecular-mass complexes containing insulin receptor substrates play important roles in regulation of insulin-like activities

    74 ( 1 )   21 - 25   2016

     More details

  • 非アルコール性脂肪性肝炎(NASH)に対するモサプリドクエン酸塩投与効果の検討

    大久保 博史, 米田 真康, 迫田 秀之, 櫛山 暁史, 藤城 緑, 中津 祐介, 福嶋 俊明, 松永 泰花, 鎌田 英明, 浅野 知一郎

    糖尿病   58 ( 1 )   51 - 51   2015.1

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • Involvement of Resistin-like Molecule beta in the Development of Nonalcoholic Steatohepatitis

    Akifumi Kushiyama, Hirofumi Okubo, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Toshiaki Fukushima, Shin-Iciro Takahashi, Tomoichiro Asano

    DIABETES   63   A466 - A466   2014.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • インスリン受容体RNAの選択的スプライシングの新しい制御機構

    成田 佑果, 尾添 淳文, 福嶋 俊明, 片岡 直行, 伊藤 昭博, 吉田 稔, 浅野 知一郎, 千田 和広, 伯野 史彦, 高橋 伸一郎

    日本内分泌学会雑誌   90 ( 1 )   285 - 285   2014.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • キサンチンオキシターゼ阻害剤FebuxostatによるNASH改善作用の検討

    藤城 緑, 中津 祐介, 福嶋 俊明, 松永 泰花, 迫田 秀之, 櫛山 暁史, 山本屋 武, 西村 英紀, 浅野 知一郎

    糖尿病   57 ( Suppl.1 )   S - 324   2014.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • 膵β細胞からのインスリン分泌におけるプロリン異性化酵素Pin1の役割

    浅野知一郎, 松永泰花, 福嶋俊明, 山崎広貴, 山本屋武, 櫛山暁史, 中津祐介

    糖尿病   57 ( Supplement 1 )   2014

  • プロリン異性化酵素Pin1はAMPKγsubunitに結合し,活性を抑制する

    中津祐介, 岩下未咲, 福嶋俊明, 菊池貴子, 櫛山暁史, 迫田秀之, 浅野知一郎

    糖尿病   57 ( Supplement 1 )   2014

  • ストレプトゾトシン処理後の膵ランゲルハンス島に対するDPP4阻害薬SK-0403の改善作用

    岩下 未咲, 大久保 博史, 迫田 秀之, 藤城 緑, 櫛山 暁史, 中津 祐介, 福嶋 俊明, 新城 尊徳, 西村 英紀, 浅野 知一郎

    糖尿病   56 ( Suppl.1 )   S - 192   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • Lactobacillus casei strain Shirota(LcS)投与による非アルコール性脂肪肝炎(NASH)の改善作用

    大久保 博史, 福嶋 俊明, 新城 尊徳, 西村 英紀, 藤代 緑, 櫛山 暁史, 菊池 貴子, 浅野 知一郎

    糖尿病   56 ( Suppl.1 )   S - 376   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • インスリン様活性と高齢化社会で克服すべき疾病

    高橋伸一郎, 伯野史彦, 亀井宏泰, Leonard Girnita, Ignacio Torres-Aleman, 東祐輔, 福嶋俊明, 柴野卓志, 尾添淳文, 山中大介

    化学と生物   51 ( 6 )   389 - 399   2013

  • プロリン異性化酵素Pin1による新規AMPK機能制御機構の解明

    中津祐介, 岩下未咲, 松永泰花, 福嶋俊明, 迫田秀之, 櫛山暁史, 鎌田英明, 内田隆史, 高橋伸一郎, 浅野知一郎

    日本分子生物学会年会プログラム・要旨集(Web)   36th   2013

  • Role of Pin1 in the Pathogenesis of Non-Alcoholic Steatohepatitis in a Rodent Model

    Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama, Toshiaki Fukushima, Fusanori Nishimura, Takafumi Uchida, Tomoichiro Asano

    DIABETES   61   A466 - A466   2012.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • Nedd4はインスリン受容体基質(IRS)-2を介したインスリン/インスリン様成長因子(IGF)のシグナル・生理活性を増強する

    福嶋 俊明, 吉原 英人, 伯野 史彦, 佐伯 泰, 田中 啓二, 伊藤 昭博, 吉田 稔, 中津 祐介, 迫田 秀之, 鎌田 英明, 高橋 伸一郎, 浅野 知一郎

    糖尿病   55 ( Suppl.1 )   S - 303   2012.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • 脂肪細胞分化におけるINTS6の役割

    大谷 裕一郎, 中津 祐介, 福嶋 俊明, 大久保 博史, 郭 瑩, 迫田 秀之, 櫛山 暁史, 浅野 知一郎

    糖尿病   55 ( Suppl.1 )   S - 189   2012.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • DPP阻害薬が炎症性サイトカイン発現ならびにインスリンシグナルへ及ぼす影響の検討

    新城 尊徳, 浅野 知一郎, 西村 英紀, 福島 俊明, 大久保 博史, 郭 榮, 岩下 未咲, 藤城 緑, 菊池 貴子

    糖尿病   55 ( Suppl.1 )   S - 117   2012.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    researchmap

  • 非アルコール性脂肪性肝炎(NASH)の発症における腸管およびマクロファージ由来レジスチン関連タンパクβ(RELMβ)の役割

    大久保博史, 郭瑩, 福嶋俊明, 櫛山暁史, 菊池貴子, 藤城緑, 浅野知一郎

    糖尿病   55 ( Supplement 1 )   2012

  • 肝細胞においてNedd4はインスリン受容体基質(IRS)-2のユビキチン化を介してインスリンシグナルを増強する

    福嶋 俊明, 吉原 英人, 伯野 史彦, 佐伯 泰, 田中 啓二, 伊藤 昭博, 中津 祐介, 鎌田 英明, 高橋 伸一郎, 浅野 知一郎

    日本生化学会大会プログラム・講演要旨集   84回   3T10p - 15   2011.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • プロリン異性化酵素Pin1類似蛋白Par14/17の生理的役割解明

    大野 晴也, 中津 祐介, 大谷 裕一郎, 福嶋 俊明, 迫田 秀之, 櫛山 暁史, 藤城 緑, 菊池 貴子, 西村 英紀, 浅野 知一郎

    糖尿病   54 ( Suppl.1 )   S - 156   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • レジスチン関連蛋白β(RELMβ)の非アルコール性脂肪性肝炎(NASH)の発症における役割

    大久保 博史, 中津 祐介, 大野 晴也, 櫛山 暁史, 福嶋 俊明, 迫田 秀之, 藤城 緑, 西村 英紀, 浅野 知一郎

    糖尿病   54 ( Suppl.1 )   S - 323   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • 非アルコール性脂肪性肝炎(NASH)の発症におけるプロリン異性化酵素Pin1の役割

    迫田 秀之, 中津 祐介, 大久保 博史, 大野 晴也, 櫛山 暁史, 福嶋 俊明, 藤城 緑, 菊池 貴子, 門脇 孝, 浅野 知一郎

    糖尿病   54 ( Suppl.1 )   S - 322   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • 転写共役因子CRTC3は高脂肪食によって発現誘導され、脂肪細胞分化と肝糖新生を促進する

    浅野 知一郎, 中津 祐介, 大谷 裕一郎, 櫛山 暁史, 福嶋 俊明, 藤城 緑, 迫田 秀之

    糖尿病   54 ( Suppl.1 )   S - 132   2011.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    J-GLOBAL

    researchmap

  • Trk(Trk-fused gene)はPTENに結合し,細胞内PIP3量を増加させることで,インスリン作用を促進させる

    大谷裕一郎, 中津祐介, 迫田秀之, 藤城緑, 菊池貴子, 櫛山暁史, 福嶋俊明, 西村英紀, 浅野知一郎

    糖尿病   54 ( Supplement 1 )   2011

  • インスリン受容体基質(IRSs)はsnoRNAと相互作用する

    尾添 淳文, 曽根 芽里, 福嶋 俊明, 片岡 直行, 浅野 知一郎, 千田 和広, 伯野 史彦, 高橋 伸一郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   2P - 0121   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • インスリン受容体基質(IRS)とそれを脱ユビキチン化する酵素USP7の相互作用機構の解明

    吉原 英人, 福嶋 俊明, 佐伯 泰, 田中 啓二, 浅野 知一郎, 千田 和広, 伯野 史彦, Takahashi 伸一郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   4P - 0561   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • エネルギー状態によるCRTC3の発現調節と脂肪分化における役割の解明

    中津 祐介, 迫田 秀之, 櫛山 暁史, 張 君, 福嶋 俊明, 内田 隆史, 鎌田 英明, 浅野 知一郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   4P - 1063   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 新規Pin1結合タンパクTrk-fused geneはAktの活性化を促進する

    大崎 慶子, 中津 祐介, 迫田 秀之, 櫛山 暁史, 大野 晴也, 磯辺 俊明, 内田 隆史, 福嶋 俊明, 鎌田 英明, 浅野 知一郎

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   4P - 1066   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • SGA short stature with IGF-I receptor mutation

    Yuki Kawashima, Naoki Miyahara, Rei Nishimura, Jun-ichi Nagaishi, Keiichi Hanaki, Toshiaki Fukushima, Shin-Ichiro Takahashi, Susumu Kanzaki

    ENDOCRINE JOURNAL   57   S322 - S322   2010.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • Complex interplay in metabolic actions of growth hormone, insulin-like growth factors, and insulin

    57 ( 4 )   307 - 318   2009

     More details

  • Molecular mechanisms in induction of appropriate biological activities of IGF: The physiological significance of potentiation of IGF signaling by other factors

    55   295 - 306   2007

     More details

  • Possible roles of cAMP-specific phosphodiesterases in cell cycle progression of cultured FRTL-5 thyroid cells induced by TSH and IGF-I

    TAKAHASHI Shinichiro, NEDACHI Taku, FUKUSHIMA Toshiaki, OKI Noriko, UMEZAKI Kohta, ITO Yoshiaki, HAKUNO Fumihiko, WYK Judson J. Van, CONTI Marco

    50 ( 2 )   73 - 81   2002.2

     More details

    Language:Japanese  

    CiNii Books

    researchmap

▼display all

Presentations

  • Deubiquitinating enzyme USP8 controls proliferative signals and cell division, and its constitutive activation causes neoplastic diseases International conference

    Toshiaki Fukushima

    International Symposium on “Signals for Human, Animal and Planetary Health: From Metabolites To Biological Interactions”  2024.3 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Tokyo  

    researchmap

  • ACTH産生下垂体腫瘍におけるWW-like領域を含めたUSP8体細胞変異の解析

    辻本 泰貴, 山本 直希, 福嶋 俊明, 駒田 雅之, 大町 侑香, 本村 悠馬, 大井 佑夏, 佐々木 百合子, 鈴木正暉, 浦井 伸, 坂東 弘教, 山本 雅昭, 井口 元三, 西岡 宏, 山田 正三, 小川 渉, 福岡 秀規

    第97回日本内分泌学会総会  2024.6 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:横浜  

    researchmap

  • クッシング病を引き起こすUSP8の過剰活性化機構

    福嶋 俊明, 柿原 慧遵, 浅水 謙吾, 森次 圭, 北口 哲也, 駒田 雅之

    第95回 日本生化学会大会シンポジウム「ユビキチンワールドを制御する脱ユビキチン化酵素の疾患、創薬における重要性」  2022.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:名古屋  

    researchmap

  • Ubiquitination-mediated activation of AKT and its cancer-associated mutants

    Marsya Yonna Nurrachma, Beni Lestari, 駒田 雅之, 福嶋 俊明

    第45回 日本分子生物学会年会  2022.11 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:千葉  

    researchmap

  • 脱ユビキチン化酵素USP8によるVAMP8の制御とその細胞質分裂における意義の解明

    西岡 柚香, 柿原 慧遵, 遠藤 彬則, 駒田 雅之, 福嶋 俊明

    第45回 日本分子生物学会年会  2022.11 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:千葉  

    researchmap

  • Comparative Phylogenetic Analysis and Molecular Characterization Reveal Eutherian-Specific Role of NRK in Regulating Placenta Development

    BENI Lestari, 内藤 聡美, 遠藤 彬則, 西原 秀典, 加藤 明, 渡邊 恵理香, 傳田 公紀, 駒田 雅之, 福嶋 俊明

    日本分子生物学会年会  2021.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:横浜  

    researchmap

  • 脱ユビキチン酵素USP8はレンチウイルス粒子へのウイルスRNAの動員を阻害することによってウイルスの増殖を防ぐ

    氷見 雄哉, 柿原 慧遵, 加藤 明, 駒田 雅之, 福嶋 俊明

    日本分子生物学会年会  2021.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:横浜  

    researchmap

  • 脱ユビキチン化酵素USP8の自己阻害機構とクッシング病関連変異によるその解除

    柿原慧遵, 浅水謙吾, 森次圭, 北口哲也, 遠藤彬則, 木寺詔記, 池口満徳, 駒田雅之, 福嶋俊明

    第44回日本分子生物学会年会  2021.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • USP8 の機能異常は様々な疾患の発症・増悪に関与する

    福嶋俊明

    新学術領域「ケモユビキチン」第6回班会議(オンライン)  2022.2 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Development of Anthracene-Based Fluorescent Probes for Application in Cellular Systems International conference

    Junya Adachi, Toshiaki Fukushima, Haruka Oda, Hiroka Sugai, Kohei Sato, Hiroshi Kimura, Kazushi Kinbara

    The 19th International Symposium on Novel Aromatic Compounds  2022.7 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 脱ユビキチン化酵素USP8の遺伝子変異を介したクッシング病の発症メカニズム

    福嶋 俊明, 柿原 慧遵, 駒田 雅之

    第27回 日本病態プロテアーゼ学会学術集会  2022.8 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:松山  

    researchmap

  • 非TICT型粘度応答性蛍光プローブの開発と生細胞イメージングへの適用

    足立惇弥, 福嶋 俊明, 小田 春佳, 菅井 祥加, 佐藤 浩平, 木村 宏, 金原 数

    2022年光化学討論会  2022.9 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Autoinhibition of USP8 by WW-like domain and the dysregulation in Cushing’s disease International conference

    Keijun Kakihara, Kei Moritsugu, Tetsuya Kitaguchi, Akinori Endo, Masayuki Komada, Toshiaki Fukushima

    EMBO Workshop “Ubiquitin and ubiquitin-like proteins in health and disease”  2022.9 

     More details

    Language:English   Presentation type:Poster presentation  

    Venue:Cavtat  

    researchmap

  • SNAREタンパク質VAMP8・STX17のユビキチン化がオートファジーの進行に果たす役割

    西岡 柚香, 遠藤 彬則, 駒田 雅之, 福嶋 俊明

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • ユビキチン化依存的なGagとALIXの相互作用によってレンチウイルスRNAのウイルス粒子への取り込みが促進される

    萩生田 健太, 氷見 雄哉, 柿原 慧遵, 駒田 雅之, 福嶋 俊明

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • Development of a new method for identifying ubiquitin-binding proteins based on the Split-TurboID technology

    Marsya Nurrachma, Beni Lestari, Masayuki Komada, Toshiaki Fukushima

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:English   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • Caspase-dependent STAMBPL1 cleavage promotes cell death through its C-terminal fragment with hyperactive deubiquitinating activity International conference

    Keijun Kakihara, Masayuki Komada, Toshiaki Fukushima

    The International Symposium in Tokyo 2022 “Ubiquitin New Frontier “from Neo-Biology to Target Protein Degradation”  2023.12 

     More details

    Language:English   Presentation type:Poster presentation  

    Venue:東京都  

    researchmap

  • Molecular mechanisms underlying the over-activation of USP8 and USP48 by Cushing’s disease-associated mutations International conference

    Gai Ando, Keijun Kakihara, Masayuki Komada, Toshiaki Fukushima

    The International Symposium in Tokyo 2022 “Ubiquitin New Frontier “from Neo-Biology to Target Protein Degradation”  2022.12 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    Venue:東京都  

    researchmap

  • Cis-activity regulation of USP8 and STAMBPL1, two endosomal deubiquitinating enzymes, and role of dysregulation in disease onset International conference

    Keijun Kakihara, Masayuki Komada, Toshiaki Fukushima

    TMiMS国際シンポジウム「New Frontiers in Ubiquitin Proteasome System」  2022.12 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    Venue:東京都  

    researchmap

  • 粘度応答性蛍光プローブの開発と生細胞内における応答性

    足立 惇弥, 福嶋 俊明, 小田 春佳, 菅井 祥加, 佐藤 浩平, 木村 宏, 金原 数

    第17回バイオ関連化学シンポジウム  2023.9 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:千葉県  

    researchmap

  • NRKによるCK2活性制御の構造モデリングと解析

    吉村 玲奈, Beni Lestari, 福嶋 俊明, 森次 圭

    第61回日本生物物理学会  2023.11 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:名古屋  

    researchmap

  • 脱ユビキチン化酵素USP48の活性制御機構とクッシング病関連変異による制御異常

    安藤 凱, 森次 圭, 木寺 詔紀, 柿原 慧遵, 駒田 雅之, 福嶋 俊明

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • 卵巣プロテオミクスによるプロテインキナーゼ NRKの機能解明

    傳田 公紀, 清田 雅哉, Wong Sing Ying, 伏見 海, 加藤 明, Beni Lestari, 福嶋 俊明, 駒田 雅之, 林 宣宏

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • 活性型ユビキチンプローブを用いたプロファイリングによる細胞老化関連DUBの同定

    倉持 七海, 駒田 雅之, 福嶋 俊明

    第46回日本分子生物学会年会  2023.12 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸  

    researchmap

  • USP8遺伝子変異によるクッシング病発症機構解明の新展開

    福嶋 俊明

    第2回ユビキチン研究会  2019.1 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • Molecular mechanisms underlying the control of Nrk protein levels and Nrk-mediated anti-proliferation effects

    Satomi Naito, Akinori Endo, Toshiaki Fukushima, Kimitoshi Denda, Akira Kato, Masayuki Komada

    Annual Meeting of the Molecular Biology Society of Japan  2018.11 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Nuclear localization mechanism of deubiquitinating enzyme USP8 in Cushing’s disease

    Takahiro Sawada, Kazuya Inoko, Kohei Kawaguchi, Akinori Endo, Yasushi Saeki, Keiji Tanaka, Toshiaki Fukushima, Masayuki Komada

    Annual Meeting of the Molecular Biology Society of Japan  2018.11 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Deubiquitinases USP5 and USP13 are recruited to and regulate heat-induced stress granules by deubiquitinating activities. International conference

    Xie Xuan, Shunsuke Matsumoto, Akinori Endo, Toshiaki Fukushima, Hiroyuki Kawahara, Yasushi Saeki, Masayuki Komada

    Cold Spring Harbor Asia Conferences, Ubiquitin Family, Autophagy and Diseases  2018.4 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Ubiquitin-specific protease 8 suppresses collagen secretion by deubiquitinating Sec31

    Kohei Kawaguchi, Akinori Endo, Toshiaki Fukushima, Masayuki Komada

    Cell and Developmental Biology Meeting  2018.6 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • USP8 遺伝子のゲノム編集によるCushing 病モデル細胞の作製と解析

    待鳥 卓, 猪子 和也, 川口 紘平, 遠藤 彬則, 福嶋 俊明, 駒田 雅之

    第33回日本下垂体研究会学術集会  2018.8 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • USP8, a deubiquitinating enzyme in the endocytic pathway, plays roles in proteostasis in the secretory pathway. International conference

    Toshiaki Fukushima

    Tokyo Tech WRHI-Cell Biology Center Mini-Symposium on Proteostasis in the Cell  2018.8 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 脱ユビキチン化酵素USP8の遺伝子変異に起因するACTH過剰産生の分子機構

    福嶋俊明, 澤田崇広, 猪子和也, 待鳥卓, 遠藤彬則, 駒田雅之

    第2回 POMC研究者の集い  2018.9 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • A deubiquitinase USP8, a master regulator of endosome-centered membrane traffic, controls inter-cellular signal transduction.

    Akinori Endo, Toshiaki Fukushima, Masayuki Komada

    Annual Meeting of the Molecular Biology Society of Japan  2018.11 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 14-3-3 protein regulates USP8-STAM1 complex formation and the subcellular localization

    Arakaki Saki, Toshiaki Fukushima

    新学術領域「ケモユビキチン」第3回班会議  2019.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • The mechanism of action of wild-type and Cushing's disease-associated mutant USP8

    Toshiaki Fukushima

    新学術領域「ケモユビキチン」第3回班会議  2019.12 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Nik-related kinase is regulated by quality control ubiquitin ligase CHIP

    Satomi Naito, Akinori Endo, Kimitoshi Denda, Akira Kato, Masayuki Komada, Toshiaki Fukushima

    新学術領域「ケモユビキチン」第3回班会議  2019.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 脱ユビキチン化酵素USP8の自己活性抑制機構

    柿原慧遵, 浅水謙吾, 遠藤彬則, 駒田雅之, 福嶋俊明

    第2回ユビキチン研究会  2019.1 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • The mechanism of action of deubiquitinating enzyme USP8 revealed by chemo-technologies

    Toshiaki Fukushima

    新学術領域「ケモユビキチン」第2回班会議  2019.6 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • 脱ユビキチン化酵素 USP8 の自己活性抑制機構

    柿原 慧遵, 浅水 謙吾, 遠藤 彬則, 駒田 雅之, 福嶋 俊明

    2019年度日本生化学会関東支部例会  2019.6 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • USP8-STAM1 deubiquitinating enzyme complex is a novel drug target for Cushing's disease International conference

    Toshiaki Fukushima

    Targeted Protein Degradation Forum in Japan  2019.8 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • A novel autoinhibitory mechanism of ubiquitin-specific protease 8 activity via the intramolecular interaction

    Keijun Kakihara, Kengo Asamizu, Akinori Endo, Masayuki Komada, Toshiaki Fukushima

    The 92nd Annual Meeting of the Japanease Biochemical Society  2019.9 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • Constitutive formation of USP8-STAM1 complex plays an important role in the onset of Cushing’s disease International conference

    Toshiaki Fukushima, Yuka Madoka, Akinori Endo, Kohei Kawaguchi, Saki Arakaki, Masayuki Komada

    The 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO)  2019.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Nrk prevents hyperplasia by modulating CK2-PTEN-Akt signaling pathway International conference

    Satomi Naito, Akinori Endo, Kimitoshi Denda, Yuka Madoka, Akira Kato, Masayuki Komada, Toshiaki Fukushima

    The 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO)  2019.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • A novel autoinhibitory mechanism of ubiquitin-specific protease 8 activity via the intramolecular interaction International conference

    Keijun Kakihara, Kengo Asamizu, Akinori Endo, Masayuki Komada, Toshiaki Fukushima

    The 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO)  2019.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

▼display all

Industrial property rights

  • クッシング病治療剤のスクリーニング方法

    福嶋俊明

     More details

    Applicant:国立大学法人東京工業大学

    Application no:特願2018-244180  Date applied:2018.12

    Announcement no:特開2020-106356  Date announced:2020.7

    researchmap

Awards

  • カイオム賞

    2018.11   株式会社カイオム・バイオサイエンス  

     More details

  • 長瀬研究振興賞

    2018.4   長瀬財団  

     More details

  • 最優秀発表賞

    2011.3   Gordon Research Conference “Insulin like growth factors in physiology and disease”  

     More details

  • ホットトピックス賞

    2006.11   国際成長ホルモン・成長因子学術会議  

     More details

Research Projects

  • Mechanistic Investigation of ACTH Regulation Mediated by the USP Family of Deubiquitinating Enzymes

    Grant number:25K02700  2025.4 - 2028.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\18850000 ( Direct Cost: \14500000 、 Indirect Cost:\4350000 )

    researchmap

  • 胎盤特異的に発現する増殖因子シグナル調節タンパク質による胎盤の発達や機能の制御

    Grant number:22K06039  2022.4 - 2025.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    福嶋 俊明

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    researchmap

  • 高性能中分子医薬のスマートデザイン基盤技術を用いたUSP8阻害ペプチドの開発

    2022 - 2023

    Sponsored Research Program (Governmental)  橋渡し研究プログラム

      More details

  • USP8の自己阻害機構の理解に基づく阻害剤開発とクッシング病治療への応用

    Grant number:21H00276  2021.4 - 2023.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    福嶋 俊明

      More details

    Grant amount:\7280000 ( Direct Cost: \5600000 、 Indirect Cost:\1680000 )

    researchmap

  • クッシング病の治療薬開発を目指したUSP8-STAM1複合体を作用点とするACTH分泌制御物質の開発

    2020 - 2021

    Sponsored Research Program (Governmental)  橋渡し研究戦略的推進プログラム

      More details

  • ケモテクノロジーを活用した脱ユビキチン化酵素USP8の作用機構の解明

    Grant number:19H05289  2019.4 - 2021.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    福嶋 俊明

      More details

    Grant amount:\8060000 ( Direct Cost: \6200000 、 Indirect Cost:\1860000 )

    脱ユビキチン化酵素の一つubiquitin-specific protease 8(USP8)は、エンドサイトーシスによって細胞内に取り込まれた膜タンパク質をエンドソームで脱ユビキチン化し、これらの細胞膜へのリサイクリングを促進する役割を果たすことが示唆されている。また、USP8の遺伝子変異は難治性疾患クッシング病の原因となることも知られている。しかし、野生型USP8がどのようなしくみでエンドソーム周辺で活性化するか、変異型USP8がどのようなしくみでクッシング病を引き起こすかは、不明である。本研究ではこれらのしくみを分子レベルで解明することを目的としている。
    野生型USP8は、14-3-3タンパク質と結合することによって活性が抑制されることがこれまで知られていた。今年度の解析から、USP8の自己阻害ドメインとUSPドメインの分子内結合を14-3-3タンパク質が強めることが明らかとなり、この分子機構を介して、USP8の活性が抑制されることが明らかになった。USP8と14-3-3タンパク質の結合が何らかの機構によってエンドソーム周辺で解除され、USP8の活性が適切に制御されている可能性が考えられた。
    一方、クッシング病を引き起こす変異型USP8についても作用機構を調べた。その結果、変異によってUSP8は14-3-3タンパク質と結合できなくなり、過剰な脱ユビキチン化活性を示すようになることが明らかとなった。このことから、USP8の過剰活性化が疾患発症機構の一部であり、USP8を阻害することがクッシング病の治療に有効である可能性が考えられた。さらに、USP8の遺伝子変異の影響をin vivoで検討するために、ゲノム編集技術を用いて、当該変異を有するマウスを作製することに成功した。

    researchmap

  • Regulatory mechanism of ubiquitin modification of insulin receptor substrates and its physiological and pathological significance.

    Grant number:18H03972  2018.4 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (A)

    Takahashi Shin-Ichiro

      More details

    Grant amount:\44330000 ( Direct Cost: \34100000 、 Indirect Cost:\10230000 )

    Insulin receptor substrates (IRSs) are essential for the induction of a wide range of physiological activities of the anabolic hormone insulin/insulin-like growth factor (insulin-like activities), which lead to healthy life in animals. We have found that IRSs form complexes with a number of proteins (IRSAPs), which play an important role in the regulation of insulin-like activities by a completely novel mechanism. In this study, we found that IRS degradation is regulated by the interaction of specific ubiquitin ligases and deubiquitinating enzymes with IRS in response to the cellular context or in a cell-specific manner, which in turn regulates vital events important for the healthy life span of animals such as muscle differentiation and malignant transformation of cancer.

    researchmap

  • The regulatory mechanism of IRS monoubiquitination, a vital process regulating insulin/IGF signaling

    Grant number:17K08625  2017.4 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Fukushima Toshiaki

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    Insulin/insulin-like growth factors (IGFs) are essential for metabolic regulation and growth in animals. Abnormalities in the intracellular signals that they trigger in target cells can lead to the development of diabetes and cancer. In this study, we found that monoubiquitination levels of the insulin receptor substrate (IRS), which mediates the signals, are controlled by a ubiquitin ligase and deubiquitinating enzymes, thereby regulating the signal intensity by a novel mechanism. In addition, we clarified the molecular mechanism by which these enzymes recognize IRS as a substrate and the regulatory mechanism of enzyme activities.

    researchmap

  • Pathogenic mechanisms of Cushing disease caused by gain-of-function USP8 mutations

    Grant number:15H04293  2015.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Komada Masayuki, Fukushima Toshiaki, Endo Akinori, Kawaguchi Kohei

      More details

    Grant amount:\16640000 ( Direct Cost: \12800000 、 Indirect Cost:\3840000 )

    Cushing’s disease, one of intractable diseases, is caused by the hypersecretion of adrenocorticotropic hormone (ACTH) from pituitary tumors. In this study, we showed that the gene encoding deubiquitinating enzyme USP8 is frequently mutated in the pituitary tumors of Japanese Cushing’s disease patients. Mechanistically, the mutation induces the increased interaction of USP8 with ubiquitin-binding protein STAM, thereby enhancing USP8 enzyme activity. The mutated form of USP8 excessively deubiquitinates some membrane proteins including EGF receptor, vasopressin receptor V1b and somatostatin receptor SSTR2/5, and affects corticotroph proliferation and hormone secretion.

    researchmap

  • Roles of Nedd4-IRS complexes in the development of diabetes and cancer

    Grant number:26460369  2014.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Fukushima Toshiaki, SAEKI Yasushi, ITO Akihiro

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    Insulin plays central roles in the regulation of glucose metabolism. Upon overnutrition, insulin target cells become resistant to insulin, and excessive resistance causes diabetes. Insulin-like growth factor (IGF) is a peptide similar in structure to insulin, and promotes body growth. Excessive sensitivity of cells to IGF contributes to hyper-proliferation and oncogenic transformation of cells. The mechanisms by which the responsiveness of cells to insulin/IGF is altered are not fully understood. In this study, we investigated intracellular signaling that is activated just after insulin/IGF binds to their membrane receptors. We found that IRS2, one of major insulin/IGF signal transducer proteins, associates with a protein called Nedd4. Our study indicated that the excessive disassembly of this Nedd4-IRS2 complex leads to insulin resistance and diabetes, whereas the excessive assembly contributes to hyper-proliferation of cancer cells.

    researchmap

  • Roles of Pin1 and PAR 14 on the metabolic regulations

    Grant number:26293219  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Asano Tomoichiro, SAKODA HIDEYUKI, FUJISHIRO MIDORI, HONDA HIROAKI

      More details

    Grant amount:\16900000 ( Direct Cost: \13000000 、 Indirect Cost:\3900000 )

    Prolyl isomerases are divided into three groups, the FKBP family, Cyclophilin and the Parvulin family (Pin1 and Par14). Pin1 is a unique prolyl isomerase binding to the motif including pSer/pThr-Pro that is phosphorylated by kinases. We have newly demonstrated Pin1 to be involved in regulating glucose and lipid metabolism. Interestingly, while Pin1 expression is markedly increased by high-fat diet feeding, Pin1 KO mice are resistant to diet-induced obesity, non-alcoholic steatohepatitis (NASH) and diabetic vascular dysfunction. These phenomena result from the binding of Pin1 to several key factors regulating metabolic functions, which include insulin receptor substrate-1, AMPK, Crtc2 and NF-kappaB p65.

    researchmap

  • Roles of trk-fused gene product protein

    Grant number:26670451  2014.4 - 2016.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    Asano Tomoichiro, NAKATSU YUSUKE, FUKUSHIMA TOSHIAKI, SAKODA HIDEYUKI, FUJISHIRO MIDORI, HONDA HIROAKI

      More details

    Grant amount:\3640000 ( Direct Cost: \2800000 、 Indirect Cost:\840000 )

    We identified TFG asa a protein which binds to PTEN. In fact, overexpression of TFG in the cultured cells induced an increased intracellular content of PIP3. In addition, recent reports revealed the TFG gene to be responsible for the occurence of nerurogenerative diseases. Thus, we generated tissue- specific TFG KO mice, to elucidate the roles of TFG on metabolic as well as neural functions. We found the reduced mass of pancreatic beta cells and impaired glucose-induced insulin secretion in the beta cell specific TFG KO mice. Therefore, TFG plays a critical role on not only the neural function, but also glucose metabolism via the regulation of insulin secretion. At present, we are trying to reveal the detailed machanisms underlying TFG-induced regulation of insulin secretion.

    researchmap

  • Development of methods to regulate abnormality of insulin-like activity by modulation of function of insulin receptor substrates-associated complex

    Grant number:25221204  2013.5 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (S)  Grant-in-Aid for Scientific Research (S)

    Takahashi Shin-Ichiro, Chida Kazuhiro, Kataoka Naoyuki, Yamanaka Daisuke, Fukushima Toshiaki, Asano Tomoichiro, Takenaka Asako, Higashi Yusuke, Girnita Leonard, Torres-Aleman Ignacio, Duan Cunming, Weghuber Julian, Belfiore Antonino, O'Connor Rosemary, Forbes Briony

      More details

    Grant amount:\215800000 ( Direct Cost: \166000000 、 Indirect Cost:\49800000 )

    Insulin-like growth factors (IGFs) and insulin induce a variety of bioactivities, including growth, differentiation, survival, increased anabolism, and decreased catabolism in many cell types and in vivo. Insulin receptor substrates (IRSs) are known to be major substrates of their receptor kinases, mediating IGF/insulin signals to direct bioactivities. In this study, we discovered that IRSs form high-molecular-mass complexes (IRSomes) even without IGF/insulin stimulation. These complexes contain proteins (IRSAPs), which modulate tyrosine phosphorylation of IRSs by receptor kinases, control IRS stability, determine intracellular localization of IRSs, and regulate RNA metabolism, as well as RNAs themselves. In addition, we demonstrated that low molecular weight compounds which modulate interaction between IRS and the specific IRSAPs can improve symptoms of various age-related diseases including cancer and diabetes, disorder of modulation of insulin-like activities.

    researchmap

  • Novel regulatory mechanism of insulin activity through IRS monoubiquitination

    Grant number:24790928  2012.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    FUKUSHIMA Toshiaki

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Insulin is a hormone that regulates blood glucose levels. Insulin-like growth factor (IGF) is another hormone similar in molecular structure to insulin, and IGF promotes cell proliferation and body growth. We previously found that insulin receptor substrate (IRS), a protein that mediates insulin/IGF intracellular signaling, is functionally changed by its modification called as "monoubiquitination", and it leads to the enhancement of insulin/IGF signaling and induction of their bioactivities. In this study, we elucidated the detailed molecular mechanisms underlying the enhancement of insulin/IGF signaling by IRS monoubiquitination. Furthermore, we found that, when the amounts of nutrition given to hepatocytes are changed, hepatic insulin sensitivity also changed through this novel mechanism. This finding is thought to be important for understanding pathogenic mechanism of diabetes.

    researchmap

  • Physiological roles of ARF1 mRNA interacting with insulin receptor substrates

    Grant number:22780249  2010 - 2011

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    TOSHIAKI Fukushima

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    We have previously found that insulin receptor substrates(IRSs), mediators of insulin/ insulin-like growth factors(IGFs) signals, are associated with RNA. In this study, we investigated roles of the complexes. Results suggest that IRSs play multiple roles ; 1) they promote small nucleolar RNA(snoRNA) biogenesis, leading to enhanced ribosomal maturation/ activation, and 2) they regulate internal ribosome entry site(IRES)-mediated translation.

    researchmap

  • mRNAの局所的翻訳制御におけるインスリン受容体基質の新機能解明

    Grant number:21880019  2009 - 2010

    日本学術振興会  科学研究費助成事業 研究活動スタート支援  研究活動スタート支援

    福嶋 俊明

      More details

    Grant amount:\2756000 ( Direct Cost: \2120000 、 Indirect Cost:\636000 )

    申請者は、インスリン様成長因子(IGF)シグナルを仲介するインスリン受容体基質(IRS)による新しいRNA制御機構の解明を目的に研究に着手した。その結果、1.IRSと結合するRNAを特定するため、IRS-1を293細胞に発現し、相互作用するRNAをCLIP(cross-linking immunoprecipitation)法によって解析、約40種のmRNAと4種のrRNAを同定した。同定されたmRNAは、シグナル伝達、小胞輸送、RNA代謝などに関わるタンパク質をコードしていることがわかった。2.種々の領域を欠いたIRS変異体を細胞に発現し、CLIP法で解析した結果、IRSのC末端側の特定の領域がRNAと結合することがわかった。3.MCF7細胞の細胞突起伸長をタイムラプス・イメージングによって観察し、タンパク質翻訳阻害剤の処理によってIGF-I刺激に応答して起こる突起伸長が抑制されることを初めて発見した。IRS-2がIGF-I刺激によって突起伸長部位に集積すること、IRS-2の発現抑制によって突起伸長が抑制されることを併せると、「IGF-I刺激に応答してIRSと結合しているmRNAが翻訳され、翻訳産物がIRS近傍でおこる細胞突起伸長を促進する」という作業仮説が考えられた。今後は、今回同定したIRS結合mRNAに焦点を当て、これらのmRNAのIGF-I刺激による翻訳制御や、細胞運動・神経突起伸長に果たす役割を明らかにしていく予定である。

    researchmap

▼display all

Other

  • 動物がきちんと成長するしくみ -細胞増殖シグナルの新しい調節機構-

     More details

    YouTube動画
    https://www.youtube.com/watch?v=_9Dt1dLqkkM&t=324s

    researchmap

Media Coverage

  • 哺乳類の胎盤獲得に至る分子進化プロセスの一端を解明

    東京工業大学プレスリリース  https://www.titech.ac.jp/news/2022/063256  2022.3

     More details

  • Study Sheds Light on Effects of USP8 Mutations on Disease Development

    cushingsdiseasenews.com  https://cushingsdiseasenews.com/2021/11/24/study-sheds-light-effects-usp8-mutations-disease-development/  2021.11

     More details

  • 難治性疾患クッシング病の発症分子機構の一部を解明

    東京工業大学プレスリリース  https://www.titech.ac.jp/news/2021/062500  2021.11

     More details

  • コラーゲン分泌の仕組み解明 Newspaper, magazine

    化学工業日報  2018.6

     More details

  • 細胞のコラーゲン分泌機構の一部を解明

    東京工業大学プレスリリース  https://www.titech.ac.jp/news/2018/041646  2018.6

     More details

  • ストレス顆粒の消失促す脱ユビキチン化酵素を発見

    東京工業大学プレスリリース  https://www.titech.ac.jp/news/2018/041594  2018.5

     More details

  • 乳がんを抑制する新たな遺伝子を発見―ヒト乳がんの診断・治療への応用に期待― Internet

    東京工業大学プレスリリース  https://www.titech.ac.jp/news/2016/036111  2016.9

     More details

  • 動物の成長や細胞の増殖の新しい調節機構を発見-インスリン受容体基質のユビキチン化の知られざる意義- Internet

    広島大学プレスリリース  https://www.hiroshima-u.ac.jp/news/35286  2015.5

     More details

  • 広島大学、東京大学、動物の成長や細胞の増殖の新しい調節機構を発見 Internet

    日経バイオテク  https://bio.nikkeibp.co.jp/article/pressrelease/20150505/184397/  2015.5

     More details

▼display all